This article assesses the evidence for effectiveness, adverse effects and cost-effectiveness of complementary therapies, as reflected in publications in high impact factor medical journals during the years 2012-2014. The search detected 13 randomized controlled studies (RCTs) and 14 meta-analyses, which collectively assessed results of 191 RCTs involving the participation of several thousand patients. Pain was the major focus of acupuncture research in both clinical and fMRI studies, which demonstrated that the effect of acupuncture is beyond the placebo effect. In addition, RCTs supported the use of acupuncture as an adjunctive therapy in chronic obstructive pulmonary disease and in moderate to severe depression. A promising trend was reported for the ameliorating effect of acupuncture in gout. Spinal manipulations may be helpful in cervical pain and yoga may be a useful treatment option for chronic neck pain, chronic low back pain and for pain-related disability. Beneficial effects of adding hypnosis and massage therapy to the treatment of fibromyalgia patients were also documented. Tai-chi may reduce balance impairment in mild-to-moderate Parkinson's disease and improve symptoms in patients with osteoarthritis. Products containing cranberry are associated with protective effects in some subgroups of patients with recurrent urinary tract infections. Chinese herbs may assist in glycemic control of diabetes patients and improve survival rate of patients with non-small cell lung cancer. Some of the complementary therapies were found to be cost-effective. Physicians should be aware of the possible adverse effects of these treatments and of possible drug-herb interactions. Further larger scale trials are justified.
BACKGROUND: Traditional, complementary, alternative and integrative medicine (TCAIM) can be described as diverse medical and healthcare interventions, practices, products, or disciplines that are not considered as part of conventional medicine. Inherent in its definition, TCAIMs are comprised of a wide variety of therapies with highly variable safety and effectiveness evidence profiles. Despite this, the use of many TCAIMs is highly prevalent among patients globally. The present study consists of a bibliometric analysis of TCAIM journals. METHODS: A single search of all International Standard Serial Number (ISSNs) of all journals categorized as "complementary and alternative medicine" (code 2707) based on the All Science Journal Classification (ASJC) was run on Scopus on April 17, 2021. All publication types were included; no further search limits were applied. The following bibliometric data were collected: number of publications (in total and per year), authors and journals; open access status; journals publishing the highest volume of literature and their impact factors; language, countries, institutional affiliations, and funding sponsors of publications; most productive authors; and highest-cited publications. Trends associated with this subset of publications were identified and presented. Bibliometric indicators of production were calculated, and bibliometric networks were constructed and visualized using the software tool VOSviewer. RESULTS: A total of 172,466 publications (42,331 open access), were published by 219,680 authors in 143 journals from 1938 to 2021. Since the 1940s, an upward trend with respect to the volume of publications can be observed, with a steep increase observed between the mid-2000s and mid-2010s. The journal that published the largest number of publications was the Journal of Natural Products (n = 15,144). The most productive countries included China (n = 45,860), the United States (n = 29,523), and Germany (n = 10,120); a number of the most common institutional affiliations and funding sponsors also originated from these three countries. CONCLUSIONS: The number of publications collectively published in TCAIM journals follows an upward trend. Given a high prevalence of TCAIM use among patients, increased acceptance of TCAIM among conventional healthcare providers, and growing interest in the research of TCAIM, future work should continue to investigate and track changes in the publication characteristics of the emerging research on this topic.
Abstract Background: Complementary, alternative and integrative medicine (CAIM) can be described as diverse medical and healthcare interventions, practices, products, or disciplines that are not considered as part of conventional medicine. Inherent in its definition, CAIMs are comprised of a wide variety of therapies with highly variable safety and effectiveness evidence profiles. Despite this, the use of many CAIMs is highly prevalent among patients globally. The present study consists of a bibliometric analysis of CAIM journals. Methods: A single search of all International Standard Serial Number (ISSNs) of all journals categorized as “complementary and alternative medicine” (code 2707) based on the All Science Journal Classification (ASJC) was run on Scopus on April 17, 2021. All publication types were included; no further search limits were applied. The following bibliometric data were collected: number of publications (in total and per year), authors and journals; open access status; journals publishing the highest volume of literature and their impact factors; language, countries, institutional affiliations, and funding sponsors of publications; most productive authors; and highest-cited publications. Trends associated with this subset of publications were identified and presented. Bibliometric networks were constructed and visualized using the software tool VOSviewer. Results: A total of 172466 publications (42331 open access), were published by 219680 authors in 143 journals from 1938 to 2021. Since the 1940s, an upward trend with respect to the volume of publications can be observed, with a steep increase observed between the mid-2000s and mid-2010s. The journal that published the largest number of publications was the Journal of Natural Products (n=15144). The most productive countries included China (n=45860), the United States (n=29523), and Germany (n=10120); a number of the most common intuitional affiliations and funding sponsors also originated from these three countries. Conclusions: The number of publications collectively published in CAIM journals follows an upward trend. Given a high prevalence of CAIM use among patients, increased acceptance of CAIM among conventional healthcare providers, and growing interest in the research of CAIM, future work should continue to investigate and track changes in the publication characteristics of the emerging research on this topic.
BACKGROUND: Open science practices are implemented across many scientific fields to improve transparency and reproducibility in research. Complementary, alternative, and integrative medicine (CAIM) is a growing field that may benefit from adoption of open science practices. The efficacy and safety of CAIM practices, a popular concern with the field, can be validated or refuted through transparent and reliable research. Investigating open science practices across CAIM journals by using the Transparency and Openness Promotion (TOP) guidelines can potentially promote open science practices across CAIM journals. The purpose of this study is to conduct an audit that compares and ranks open science practices adopted by CAIM journals against TOP guidelines laid out by the Center for Open Science (COS). METHODS: CAIM-specific journals with titles containing the words "complementary", "alternative" and/or "integrative" were included in this audit. Each of the eight TOP criteria were used to extract open science practices from each of the CAIM journals. Data was summarized by the TOP guideline and ranked using the TOP Factor to identify commonalities and differences in practices across the included journals. RESULTS: A total of 19 CAIM journals were included in this audit. Across all journals, the mean TOP Factor was 2.95 with a median score of 2. The findings of this study reveal high variability among the open science practices required by journals in this field. Four journals (21%) had a final TOP score of 0, while the total scores of the remaining 15 (79%) ranged from 1 to 8. CONCLUSION: While several studies have audited open science practices across discipline-specific journals, none have focused on CAIM journals. The results of this study indicate that CAIM journals provide minimal guidelines to encourage or require authors to adhere to open science practices and there is an opportunity to improve the use of open science practices in the field.
Objective Journal of Complementary and Integrative Medicine ( JCIM ) focuses on evidence concerning the efficacy and safety of complementary medical (CM) whole systems, practices, interventions and natural health products, including herbal and traditional medicines. The journal is edited by Ed Lui of the University of Western Ontario. Topics Quality, efficacy, and safety of natural health products, dietary supplements, traditional medicines and their synthetic duplicates Efficacy and safety of complementary therapies Evidence-based medicine and practice, including evidence of traditional use Curriculum development, educational system and competency of complementary health programs Methodologies on research and evaluation of traditional medicines and herbal products Integrative medicine: basic and clinical research and practice Innovation in CAM Curriculum Educational Material Design Article formats Research Articles, Review Articles, Mini Reviews, Discussion/Opinion Papers, Short Communications, Editorials
Publishing articles in a prestigious journal is a golden rule for university professors and researchers nowadays. Impact factor, journal rank, and citation count, included in Science Citation Index managed by Thomson Reuters Web of Science, are the most important indicators for evaluating the quality of academic journals. By listing the journals encompassed in the "Integrative and Complementary Medicine" category of Science Citation Index from 2003 to 2013, this paper examines the publication trends of journals in the category. The examination includes number, country of origin, ranking, and languages of journals. Moreover, newly listed or removed journals in the category, journal publishers, and open access strategies are examined. It is concluded that the role of journal publisher should not be undermined in the "Integrative and Complementary Medicine" category.
BACKGROUND: Bibliometric analysis is increasingly employed as a useful tool to assess the quantity and quality of research performance. The specific goal of the current study was to evaluate the performance of research output originating from Arab world and published in international Integrative and Complementary Medicine (ICM) journals. METHODS: Original scientific publications and reviews from the 22 Arab countries that were published in 22 international peer-reviewed ICM journals during all previous years up to December 31(st) 2013, were screened using the Web of Science databases. RESULTS: Five hundred and ninety-one documents were retrieved from 19 ICM journals. The h-index of the set of papers under study was 47. The highest h-index was 27 for Morocco, 21 for Jordan, followed by 19 for each Kingdom of Saudi Arabia (KSA), and Egypt, and the lowest h-index was 1 for each of Comoros, Qatar, and Syrian Arab Republic. No data related to ICM were published from Djibouti, and Mauritania. After adjusting for economy and population power, Somalia (89), Morocco (32.5), Egypt (31.1), Yemen (21.4), and Palestine (21.2) had the highest research productivity. The total number of citations was 9,466, with an average citation of 16 per document. The study identified 262 (44.3 %) documents with 39 countries in Arab-foreign country collaborations. Arab authors collaborated most with countries in Europe (24.2 %), followed by countries in the Asia-Pacific region (9.8 %). CONCLUSION: Scientific research output in the ICM field in the Arab world region is increasing. Most of publications from Arab world in ICM filed were driven by societal use of medicinal plants and herbs. Search for new therapies from available low cost medicinal plants in Arab world has motivated many researchers in academia and pharmaceutical industry. Further investigation is required to support these findings in a wider journal as well as to improve research output in the field of ICM from Arab world region by investing in more national and international collaborative research project.
This research protocol outlines a cross-sectional survey study, aimed at editors from traditional, complementary, and integrative medicine (TCIM) journals, regarding their perceptions of the use of artificial intelligence (AI) in the editorial and peer review process. The survey will be sent to editors-in-chief, associate editors, and editorial board members of TCIM journals (100-150). The research involves purposive sampling via manual collection of contact details from TCIM journal websites. The survey will include sections on demographics, current use and familiarity with AI, perceived benefits and challenges, ethical concerns, and the outlook for AI in publishing. Data collection will be conducted online using SurveyMonkey whereby email invitations and follow-up reminders will be sent to potential respondents. Quantitative data will be analyzed using descriptive statistics, and for qualitative data, thematic analyses will be employed. This protocol study aimed to devise a survey which could provide insight into the acceptance and potential barriers to AI adoption in TCIM publishing from an editor’s perspective. The results of which may later guide the development of AI tools in a way that aligns with the needs and values of the TCIM research community.
The Journal of Alternative and Complementary MedicineVol. 26, No. 5 CommentariesPublic Health Approach of Ayurveda and Yoga for COVID-19 ProphylaxisGirish Tillu, Sarika Chaturvedi, Arvind Chopra, and Bhushan PatwardhanGirish TilluAYUSH Center of Excellence, Center for Complementary and Integrative Health, Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India.Search for more papers by this author, Sarika ChaturvediDr. D.Y. Patil Vidyapeeth (DPU), Pune, India.Search for more papers by this author, Arvind ChopraCenter for Rheumatic Diseases, Pune, India.Search for more papers by this author, and Bhushan PatwardhanAddress correspondence to: Bhushan Patwardhan, AYUSH Center of Excellence, Center for Complementary and Integrative Health, Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India E-mail Address: [email protected]AYUSH Center of Excellence, Center for Complementary and Integrative Health, Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India.Search for more papers by this authorPublished Online:11 May 2020https://doi.org/10.1089/acm.2020.0129AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookXLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byDNA metabarcoding uncovers fungal communities in Zingiberis RhizomaChinese Herbal Medicines, Vol. 6"We are adapting to it because it is within us": The co‐becoming of COVID‐19 in Malawi20 December 2023 | World Medical & Health Policy, Vol. 5COVID-19 Cases and Comorbidities: Complementary and Alternative Medicinal Systems (CAM) for Integrated Management of the PandemicJournal of Herbal Medicine, Vol. 42Traditional Formulations for Managing COVID-19: A Systematic Review Rudra B. Bhandari, Acharya Balkrishna, Kuppusamy Maheshkumar, and Velan A. Arumugam16 November 2023 | Journal of Integrative and Complementary Medicine, Vol. 0, No. 0Phytoconstituents from Mother Nature against SARS-CoV-2/ COVID-19Screening of Natural Antivirals Against the COVID-19 Pandemic- A Compilation of UpdatesCurrent Traditional Medicine, Vol. 9, No. 5Nasal application of sesame oil-based Anu taila as 'biological mask' for respiratory health during COVID-19Journal of Ayurveda and Integrative Medicine, Vol. 14, No. 5Overview of COVID-19 Pandemic: Its Management and Prevention in Light of the Indian Traditional Medicine SystemCurrent Traditional Medicine, Vol. 9, No. 4A Paradigm Shift in Public Health: Yoga and Meditation for Prevention30 June 2023 | DIALOGO, Vol. 9, No. 2Scientific rationale of Indian AYUSH Ministry advisory for COVID-19 prevention, prophylaxis, and immunomodulation29 April 2021 | Advances in Traditional Medicine, Vol. 23, No. 2Converging Paths: A Comprehensive Review of the Synergistic Approach between Complementary Medicines and Western Medicine in Addressing COVID-19 in 20206 June 2023 | BioMed, Vol. 3, No. 2Herbal and Ayurvedic Plants as Remedial Approach for Viral Diseases with Focus on COVID-19: A Narrative ReviewCurrent Traditional Medicine, Vol. 9, No. 3Ayurvedic Herbs and Spices: A Promising Approach for the Treatment of COVID-19The Natural Products Journal, Vol. 13, No. 3Yoga Meets Intelligent Internet of Things: Recent Challenges and Future Directions9 April 2023 | Bioengineering, Vol. 10, No. 4Exploring the Benefits of Yoga for Mental and Physical Health during the COVID-19 Pandemic17 April 2023 | Religions, Vol. 14, No. 4Yoga for COVID-19: An ancient practice for a new condition – A literature reviewComplementary Therapies in Clinical Practice, Vol. 50Traditional Medicine and Global Public Health21 January 2023COVID-19 outbreak… journey of dental care workers: A systematic reviewNational Journal of Maxillofacial Surgery, Vol. 14, No. 1Traditional Medicine and Global Public Health10 September 2023Altmetric attention analysis of Ayurveda and COVID-19 scholarly publications: A comprehensive review of top 50 high-attention publications12 December 2023 | Journal of Research in Ayurvedic Sciences, Vol. 7, No. 4TURKISH VALIDITY AND RELIABILITY OF COVID-19 STRESS SCALES (CSS)31 December 2022 | Karya Journal of Health Science, Vol. 3, No. 3A Novel Smart Belt for Anxiety Detection, Classification, and Reduction Using IIoMT on Students' Cardiac Signal and MSY12 December 2022 | Bioengineering, Vol. 9, No. 12An Ergonomic Design Process of the Functional Clothing for Yoga Sports30 December 2022 | Fibres & Textiles in Eastern Europe, Vol. 30, No. 6Can Yoga, Qigong, and Tai Chi Breathing Work Support the Psycho-Immune Homeostasis during and after the COVID-19 Pandemic? A Narrative Review2 October 2022 | Healthcare, Vol. 10, No. 10Online Yoga and Ayurveda Intervention as Tertiary Prevention of Psychological Comorbidities in COVID-19 Survivors: A Randomized Controlled Trial18 August 2022 | Annals of Neurosciences, Vol. 29, No. 4An exhaustive comprehension of the role of herbal medicines in Pre- and Post-COVID manifestationsJournal of Ethnopharmacology, Vol. 296Modeling the relationship between perceived service quality, tourist satisfaction, and tourists' behavioral intentions amid COVID-19 pandemic: Evidence of yoga tourists' perspectives23 September 2022 | Frontiers in Psychology, Vol. 13Antiviral potential of anthraquinones from Polygonaceae, Rubiaceae and Asphodelaceae: potent candidates in the treatment of SARS-COVID-19, A comprehensive reviewSouth African Journal of Botany, Vol. 35A randomized, controlled, blinded, parallel group, clinical trial to study the role of Ayurcov (AyurCoro3), one day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in IndiaComplementary Therapies in Medicine, Vol. 67Efficacy of add-on Ayurveda and Yoga intervention in health care workers of tertiary care hospital during COVID-19: Randomized controlled trialComplementary Therapies in Clinical Practice, Vol. 48The Role of Complementary and Alternative Medicines in the Treatment and Management of COVID-196 July 2022Ayurveda research-are we on the right track?Journal of Ayurveda and Integrative Medicine, Vol. 13, No. 3COVID-19 patient with B cell lymphoma co-morbidity managed with co-administration of ayurvedic formulationJournal of Ayurveda and Integrative Medicine, Vol. 13, No. 3Electro-Homeopathy based COVID-19 Safe-home Medical Management Study19 April 2022 | Journal of Natural Remedies, Vol. 22, No. 2Combating the psychological impact of COVID-19 pandemic through yoga: Recommendation from an overviewJournal of Ayurveda and Integrative Medicine, Vol. 13, No. 2Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complicationsPhytomedicine, Vol. 98COVID-19 Adaptive Interventions: Implications for Wellbeing and Quality-of-Life17 March 2022 | Frontiers in Psychology, Vol. 13THE ROLE OF HERBAL IMMUNOMODULATORS AS ADJUVANT THERAPY FOR ASYMPTOMATIC AND MILDLY SYMPTOMATIC COVID-19: AN EXPLORATORY CLINICAL STUDY9 February 2022 | Asian Journal of Pharmaceutical and Clinical ResearchRespiratory Infectious Disease and the COVID-19 Pandemic : A Review of Medieval Unani Medical Literature14 February 2022 | Journal of Natural Remedies, Vol. 22, No. 1Emerging Technological Trends and Advancements in Respiratory Medicine24 March 2022Herbal Immunomodulators and COVID-1918 June 2022COVID-19 pandemic: A pragmatic plan for ayurveda interventionJournal of Ayurveda and Integrative Medicine, Vol. 13, No. 1Influenza like illness related clinical trial on AYUSH-64 requires cautious interpretationJournal of Ayurveda and Integrative Medicine, Vol. 13, No. 1A prospective clinical study of an Ayurveda regimen in COVID 19 patientsJournal of Ayurveda and Integrative Medicine, Vol. 13, No. 1Pathophysiology of Covid-19 and host centric approaches in AyurvedaJournal of Ayurveda and Integrative Medicine, Vol. 13, No. 1Time when a physician turned out to be a patient: A case study on how an Ayurvedic physician cured himself from COVID-19Journal of Ayurveda and Integrative Medicine, Vol. 13, No. 1Modulation of neutrophil (dys)function by Ayurvedic herbs and its potential influence on SARS-CoV-2 infectionJournal of Ayurveda and Integrative Medicine, Vol. 13, No. 1Role of Ayurveda and Yoga-Based lifestyle in the COVID-19 pandemic – A narrative reviewJournal of Ayurveda and Integrative Medicine, Vol. 13, No. 1Welche Behandlungsoptionen wurden von COVID-19-infizierten Yogaübenden als hilfreich empfunden? Ergebnisse einer Querschnittsanalyse29 March 2022 | Complementary Medicine Research, Vol. 29, No. 4Understanding COVID-19 Situation in Nepal and Implications for SARS-CoV-2 Transmission and Management7 June 2022 | Environmental Health Insights, Vol. 16The effects of yoga-based breathing techniques and meditation on outpatients' symptoms of COVID-19 and anxiety scoresJournal of Nursing and Midwifery Sciences, Vol. 9, No. 3Effect of yoga mudras in improving the health of users: A precautionary measure practice in daily life for resisting the deadly COVID-19 diseaseCOVID-19 and its impact on cancer, HIV, and mentally ill patientsSiddha Medicine and Computer Modeling: A Treasure for SARS-CoV-2 Treatment2 November 2021Theoretical effectiveness of steam inhalation against SARS-CoV-2 infection: updates on clinical trials, mechanism of actions, and traditional approachesHeliyon, Vol. 8, No. 1The Effect on the Immune System in the Human Body Due to COVID-19: An Insight on Traditional to Modern Approach as a Preventive MeasureJournal of Pharmacopuncture, Vol. 24, No. 4Preventive aspect of ayurveda and yoga towards newly emerging disease COVID-1927 January 2021 | Journal of Complementary and Integrative Medicine, Vol. 18, No. 4AYURVEDIC UNDERSTANDING & PREVENTIVE MEASURES OF COVID-19: AN OVERVIEW15 December 2021 | GLOBAL JOURNAL FOR RESEARCH ANALYSISThe Future of Medicine: Frontiers in Integrative Health and Medicine28 November 2021 | Medicina, Vol. 57, No. 12The use of integrative therapy based on Yoga and Ayurveda in the treatment of a high-risk case of COVID-19/SARS-CoV-2 with multiple comorbidities: a case report24 February 2021 | Journal of Medical Case Reports, Vol. 15, No. 1A Comprehensive Overview of the Newly Emerged COVID-19 Pandemic: Features, Origin, Genomics, Epidemiology, Treatment, and Prevention25 October 2021 | Biologics, Vol. 1, No. 3Ayurveda approaches to COVID-19 in 2 wave: Lessons learned from practice15 November 2021 | Journal of Preventive Medicine and Holistic Health, Vol. 7, No. 2Yoga for Improving Mental Health during COVID-19 Pandemic: A Review15 November 2021 | Eastern Journal of Psychiatry, Vol. 23, No. 1Withania somnifera as a safer option to hydroxychloroquine in the chemoprophylaxis of COVID-19: Results of interim analysisComplementary Therapies in Medicine, Vol. 62Withania somnifera attenuates Tilapia lake virus (TiLV)‐induced mortality by inhibiting stress and strengthening the innate antioxidant defence system24 June 2021 | Aquaculture Research, Vol. 52, No. 11EFFECTS OF THE EASTERN MIND-BODY PRACTICES ON MENTAL HEALTH DURING THE COVID-19 PANDEMIC: WHEN EAST MEETS WEST1 January 2021 | Wiadomości Lekarskie, Vol. 74, No. 11Therapeutic approaches for SARS-CoV-2 infectionMethods, Vol. 195Some Igbo Indigenous Plants with Anti-COVID-19 Properties27 October 2021In-silico investigation of phytochemicals from Asparagus racemosus as plausible antiviral agent in COVID-1924 June 2020 | Journal of Biomolecular Structure and Dynamics, Vol. 39, No. 14A RANDOMIZED CONTROL STUDY TO EVALUATE THE ROLE OF HERBAL IMMUNOMODULATORS IN BOOSTING THE IMMUNITY AND OVERALL HEALTH OF HEALTHCARE WORKERS IN COVID-19 WARDS: AN EXPLORATORY, FEEDBACK CLINICAL STUDY7 August 2021 | Asian Journal of Pharmaceutical and Clinical ResearchAssociation Between Physical Exercise and Mental Health During the COVID-19 Outbreak in China: A Nationwide Cross-Sectional Study16 August 2021 | Frontiers in Psychiatry, Vol. 12Sars-cov-2 host entry and replication inhibitors from Indian ginseng: an in-silico approach22 June 2020 | Journal of Biomolecular Structure and Dynamics, Vol. 39, No. 12AN APPROACH TOWARDS THE DIAGNOSIS AND MANAGEMENT OF COVID 19 AS PER AYURVEDA15 July 2021 | International Ayurvedic Medical Journal, Vol. 9, No. 7Novel corona virus (COVID-19); Global efforts and effective investigational medicines: A reviewJournal of Infection and Public Health, Vol. 14, No. 7Candidate Anti-COVID-19 Medicinal Plants from Ethiopia: A Review of Plants Traditionally Used to Treat Viral DiseasesEvidence-Based Complementary and Alternative Medicine, Vol. 2021The Plausible Role of Indian Traditional Medicine in Combating Corona Virus (SARS-CoV 2): A Mini-ReviewCurrent Pharmaceutical Biotechnology, Vol. 22, No. 7Significance of AYUSH: India's first line of defence against COVID-19Journal of Ayurveda and Integrative Medicine, Vol. 12, No. 2Matrix metalloproteinase inhibitors identified from Camellia sinensis for COVID-19 prophylaxis: an in silico approach6 October 2020 | Advances in Traditional Medicine, Vol. 21, No. 1Integrative Medicine Treatment in Times of Pandemic Coronavirus Disease? Juan Yang, Dietlind L. Wahner-Roedler, Tony Y. Chon, and Brent A. Bauer16 February 2021 | Medical Acupuncture, Vol. 33, No. 1COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategiesEuropean Journal of Pharmacology, Vol. 892Safety and efficacy of ozone therapy in mild to moderate COVID-19 patients: A phase 1/11 randomized control trial (SEOT study)International Immunopharmacology, Vol. 91A comprehensive review on potential therapeutics interventions for COVID-19European Journal of Pharmacology, Vol. 890Randomized controlled trials of traditional, complementary, and integrative medicine-based interventions for coronavirus disease 2019 (COVID-19): A bibliometric analysis and review of study designsIntegrative Medicine Research, Vol. 10Traditional medicine is the valuable resource for global healthJournal of Traditional Chinese Medical Sciences, Vol. 8, No. 1SARS CoV-2: Progression and treatment protocols – An overviewMaterials Today: Proceedings, Vol. 46Association Between Yogic Breathing Practice With Perceived Impact of COVID-19: A Cross-Sectional Study From India30 November 2020 | Asia Pacific Journal of Public Health, Vol. 33, No. 120-Week Study of Clinical Outcomes of Over-the-Counter COVID-19 Prophylaxis and Treatment6 July 2021 | Journal of Evidence-Based Integrative Medicine, Vol. 26Emergence of Ethnomedical COVID-19 Treatment: A Literature Review1 October 2021 | Infection and Drug Resistance, Vol. Volume 14Balancing Healthcare and Economy Amidst the COVID-19 Pandemic: An Indian Experience1 February 2021 | Risk Management and Healthcare Policy, Vol. Volume 14Yoga-based lifestyle intervention as a potential adjuvant in addressing anxiety, fear, depression, and perceived health in mild-to-moderate COVID-19 patients. A pilot studyAYUHOM, Vol. 8, No. 1A holistic care approach to combat the COVID-19 diseaseJournal of Family Medicine and Primary Care, Vol. 10, No. 2Clinical evaluation of Chyawanprash as a preventive measure during the COVID-19 pandemic: An open-label, multicentric, randomized, comparative, prospective, and interventional community-based clinical study on healthy individualsJournal of Indian System of Medicine, Vol. 9, No. 2Effect of Meditation and Breathing Exercises on the Well-being of Patients with SARS-CoV-2 Infection under Institutional Isolation: A Randomized Control Trial26 November 2021 | Indian Journal of Palliative Care, Vol. 27The Relevance of Complementary and Integrative Medicine in the COVID-19 Pandemic: A Qualitative Review of the Literature11 December 2020 | Frontiers in Medicine, Vol. 7The COVID-19 Pandemic and the Relevance of Ayurveda's Whole Systems Approach to Health and Disease Management Unnikrishnan Payyappallimana, Kishor Patwardhan, Prasad Mangalath, Christian S. Kessler, Rama Jayasundar, Anupama Kizhakkeveettil, Antonio Morandi, and Rammanohar Puthiyedath9 December 2020 | The Journal of Alternative and Complementary Medicine, Vol. 26, No. 12A review on coronavirus survivability on material's surfaces: present research scenarios, technologies and future directions19 October 2020 | Surface Engineering, Vol. 36, No. 12Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update18 July 2020 | Current Pharmacology Reports, Vol. 6, No. 5The role of Yoga in working from home during the COVID-19 global lockdownWork, Vol. 66, No. 4In the Turkish News: Coronavirus and "Alternative & complementary" medicine methodsComplementary Therapies in Medicine, Vol. 53Blessings in Disguise: Yoga and Meditation during Corona Lockdown31 August 2020 | Journal of Evolution of Medical and Dental Sciences, Vol. 9, No. 35Role of Complementary and Alternative Medicine in Prevention and Treatment of COVID-19: An Overhyped Hope5 August 2020 | Chinese Journal of Integrative Medicine, Vol. 26, No. 8हठयौगिक ग्रंथों में कफ संबंधी दोषों को दूर करने के लिये वर्णित यौगिक विधिया : कोविड-19 महामारी के विशेष संदर्भ में31 July 2020 | Dev Sanskriti Interdisciplinary International Journal, Vol. 16Meditation and Yoga Practices as Potential Adjunctive Treatment of SARS-CoV-2 Infection and COVID-19: A Brief Overview of Key Subjects William Bushell, Ryan Castle, Michelle A. Williams, Kimberly C. Brouwer, Rudolph E. Tanzi, Deepak Chopra, and Paul J. Mills14 July 2020 | The Journal of Alternative and Complementary Medicine, Vol. 26, No. 7AYUSH for COVID-19 managementJournal of Ayurveda and Integrative Medicine, Vol. 11, No. 2Indians vs.COVID-19: The scenario of mental healthSensors International, Vol. 1Preventive strategies to combat infections–a review of traditional practices and Ayurveda concepts1 January 2020 | International Journal of Complementary and Alternative Medicine, Vol. 13, No. 3COVID-19: A new horizon for ayurvedaAYUHOM, Vol. 7, No. 2Ayurveda: The promising shelter for the mankind in the wake of COVID-19 pandemicJournal of Ayurveda Case Reports, Vol. 3, No. 1Epidemic containment measures in Unani medicine and their contemporary relevanceJournal of Indian System of Medicine, Vol. 8, No. 2COVID 19 in ayurvedic perspectiveInternational Journal of Health & Allied Sciences, Vol. 9, No. 5 Volume 26Issue 5May 2020 InformationCopyright 2020, Mary Ann Liebert, Inc., publishersTo cite this article:Girish Tillu, Sarika Chaturvedi, Arvind Chopra, and Bhushan Patwardhan.Public Health Approach of Ayurveda and Yoga for COVID-19 Prophylaxis.The Journal of Alternative and Complementary Medicine.May 2020.360-364.http://doi.org/10.1089/acm.2020.0129Published in Volume: 26 Issue 5: May 11, 2020Online Ahead of Print:April 20, 2020 TopicsCOVID-19Yoga PDF download
Cancer treatment and care remain challenging in countries with limited resources, often leading to delays in accessing essential medical services [1Ginsburg O. Bray F. Coleman M.P. et al.The global burden of women’s cancers: a grand challenge in global health.The Lancet. 2017; 389: 847-860Abstract Full Text Full Text PDF PubMed Scopus (0) Google Scholar]. In such circumstances, many patients and their families turn to Traditional, Complementary, and Alternative Medicine (TCAM), either as a standalone approach or in conjunction with standard treatments. Their hope is to enhance disease outcomes and mitigate the complications associated with medical interventions [2Zaid H, Silbermann M, Amash A, Gincel D, Abdel-Sattar E, Sarikahya NB. Medicinal plants and natural active compounds for cancer chemoprevention/chemotherapy. Hindawi; 2017.Google Scholar]. The World Health Organization (WHO) defines TCAM as a reservoir of knowledge, skills, and practices rooted in the theories, beliefs, and traditional experiences of diverse cultures. These practices are employed for the purpose of preserving health, preventing, diagnosing, ameliorating, or treating physical and mental illnesses [3World Health Organization. WHO traditional medicine strategy 2014–2023. 2013. Geneva: World Health Organization. 2015;Google Scholar]. Over the last few decades, there has been a notable surge in the utilization of TCAM among cancer patients. The prevalence of TCAM usage in cancer survivors exhibits significant variability, ranging from 16.5% in Italy to a staggering 93.4% in China [4Kasprzycka K. Kurzawa M. Kucharz M. et al.Complementary and Alternative Medicine Use in Hospitalized Cancer Patients—Study from Silesia, Poland.International Journal of Environmental Research and Public Health. 2022; 19: 1600Crossref PubMed Scopus (6) Google Scholar,5Keene M.R. Heslop I.M. Sabesan S.S. Glass B.D. Complementary and alternative medicine use in cancer: A systematic review.Complementary therapies in clinical practice. 2019; 35: 33-47Crossref PubMed Scopus (0) Google Scholar]. The prevalence of TCAM can be attributed to several factors: the multitude of unmet patient needs [6Wang T. Molassiotis A. Chung B.P.M. Tan J.Y. Unmet care needs of advanced cancer patients and their informal caregivers: a systematic review.BMC Palliat Care. Jul 23 2018; 17: 96https://doi.org/10.1186/s12904-018-0346-9Crossref PubMed Scopus (312) Google Scholar], rising costs of conventional treatments, their ineffectiveness, and associated complications, as well as the public's perception that traditional and natural remedies are safer and more cost-effective [7Farahani A.S. Salmani N. Khoshnazar T.A.S.K. et al.The perspective of cancer patients on the use of complementary medicine.International Journal of Cancer Management. 2019; 12Google Scholar]. Despite the numerous advantages, many of these treatments carry the potential for serious side effects, drug interactions, and are associated with various challenges. The decision to incorporate TCAM into cancer care is a complex one, influenced by various factors, including attitudes and beliefs [8Bauml J.M. Chokshi S. Schapira M.M. et al.Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey.Cancer. Jul 15 2015; 121: 2431-2438https://doi.org/10.1002/cncr.29173Crossref PubMed Scopus (62) Google Scholar], gender [9Chao M.T. Wade C.M. Socioeconomic factors and women's use of complementary and alternative medicine in four racial/ethnic groups.Ethnicity & disease. Winter. 2008; 18: 65-71PubMed Google Scholar], disease status [10Pirri C. Integrating complementary and conventional medicine. 2011:31-39.Google Scholar], social and economic status [9Chao M.T. Wade C.M. Socioeconomic factors and women's use of complementary and alternative medicine in four racial/ethnic groups.Ethnicity & disease. Winter. 2008; 18: 65-71PubMed Google Scholar], and cultural contexts [11Rassouli M, Farahan AS, Mojen LK, Ashrafizadeh H. The Impact of Culture and Beliefs on Cancer Care. Global Perspectives in Cancer Care: Religion, Spirituality, and Cultural Diversity in Health and Healing. 2022;215Google Scholar]. The proliferation of unverified anecdotes and false claims associated with TCAM can easily lead vulnerable individuals to make ill-advised decisions and potentially result in drug interactions [12Jones E. Nissen L. McCarthy A. Steadman K. Windsor C. Exploring the Use of Complementary and Alternative Medicine in Cancer Patients.Integrative Cancer Therapies. 2019; 18 (2019/01/01)1534735419846986https://doi.org/10.1177/1534735419846986Crossref Scopus (35) Google Scholar]. Approximately half of cancer patients combine TCAM with conventional cancer treatments without informing their healthcare providers, which constitutes one of the most significant challenges in this field [13Berretta M. Montella L. Integrative medicine in the cancer setting: a new challenge for physicians and patients.WCRJ. 2022; 9e2405Google Scholar]. Evidence indicates that concurrent use of TCAM and anticancer medications may lead to severe side effects and a reduced quality of life in cancer patients [14Block K.I. Significance of natural product interactions in oncology.Integrative Cancer Therapies. 2013; 12: 4-6Crossref PubMed Scopus (3) Google Scholar]. Despite the common belief that herbs, being natural products, are inherently devoid of side effects and safe [15World Health Organization. National policy on traditional medicine and regulation of herbal medicines: Report of a WHO global survey. World Health Organization; 2005.Google Scholar], TCAM is not universally free from risks, and its purported advantages such as cost-effectiveness, increased life expectancy, and enhanced quality of life have yet to be conclusively substantiated [16Hoppe C. Buntzel J. VON WEIKERSTHAL L.F. et al.Usage of complementary and alternative methods, lifestyle, and psychological variables in cancer care.in vivo. 2023; 37: 106-114Crossref PubMed Scopus (2) Google Scholar]. Numerous studies have identified side effects associated with TCAM, either independently or when used in conjunction with allopathic medicines. Some of the most prevalent side effects include gastrointestinal issues (such as nausea, vomiting, diarrhea, and abdominal pain), followed by symptoms like dizziness, headaches, and fatigue [17Duru C.B. Uwakwe K.A. Chinomnso N.C. et al.Socio-demographic determinants of herbal medicine use in pregnancy among Nigerian women attending clinics in a tertiary Hospital in Imo State, south-east, Nigeria.Am J Med Stud. 2016; 4: 1-10Google Scholar,18Laelago T. Yohannes T. Lemango F. Prevalence of herbal medicine use and associated factors among pregnant women attending antenatal care at public health facilities in Hossana Town, Southern Ethiopia: facility based cross sectional study.Archives of Public Health. 2016; 74: 1-8Crossref PubMed Google Scholar]. An additional hurdle in the utilization of TCAM is the limited availability of services, often restricted to a handful of centers and innovative delivery methods. Consequently, if patients question the quality of services, they may find it challenging to seek alternative treatments elsewhere. As TCAM gains popularity among cancer patients, certain countries have witnessed the introduction of evidence-based TCAM counseling and treatments, including herbal remedies, in many leading cancer centers [19Ben-Arye E. Samuels N. Goldstein L.H. et al.Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals.Cancer. 2016; 122: 598-610https://doi.org/10.1002/cncr.29796Crossref PubMed Scopus (84) Google Scholar]. Nonetheless, only a few of these centers have fully integrated these services into their conventional oncology settings as part of standard care [20Almog L. Lev E. Schiff E. Linn S. Ben-Arye E. Bridging cross-cultural gaps: monitoring herbal use during chemotherapy in patients referred to integrative medicine consultation in Israel.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. Oct 2014; 22: 2793-2804https://doi.org/10.1007/s00520-014-2261-9Crossref PubMed Scopus (8) Google Scholar]. Non-disclosure of TCAM usage represents another challenge, often stemming from a communication gap between physicians and patients. Patients' beliefs and narratives are frequently dismissed as superstitions, and during routine medical interviews, physicians seldom inquire about TCAM usage [21Pingoy D. CAM Use at the Cancer Institute.Philippine J Intern Med. 2004; 42: 159-171Google Scholar]. Many patients opt to keep their TCAM usage concealed due to apprehension of judgment or disapproval from their healthcare providers [22Galvez-Tan JZ. Health in the hands of the people. Book of Readings on Primary Health Care. 2013:1.Google Scholar]. As referral systems have not been universally established in various countries, cancer patients may feel abandoned and, in many instances, perceive TCAM as a safer, more accessible, and cost-effective choice, leading them to choose this alternative [23Johnson S.B. Park H.S. Gross C.P. James B.Y. Complementary medicine, refusal of conventional cancer therapy, and survival among patients with curable cancers.JAMA oncology. 2018; 4: 1375-1381Crossref PubMed Scopus (0) Google Scholar]. Other factors contributing to non-disclosure include the fear of blame and stigmatization by caregivers, caregivers failing to inquire about TCAM use from the patients [24Hill J. Mills C. Li Q. Smith J.S. Prevalence of traditional, complementary, and alternative medicine use by cancer patients in low income and lower-middle income countries.Global public health. 2019; 14: 418-430Crossref PubMed Scopus (25) Google Scholar], a lack of structured TCAM training within healthcare systems of different countries [25Mwaka A.D. Tusabe G. Garimoi C.O. Vohra S. Ibingira C. Integration of traditional and complementary medicine into medical school curricula: a survey among medical students in Makerere University, Uganda.BMJ open. 2019; 9e030316Crossref PubMed Scopus (4) Google Scholar], healthcare specialists' limited understanding of TCAM mechanisms and herb-drug interactions, and a dearth of expertise and comprehensive knowledge of medicinal plants among many oncology care providers [26Trimborn A. Senf B. Muenstedt K. et al.Attitude of employees of a university clinic to complementary and alternative medicine in oncology.Annals of oncology : official journal of the European Society for Medical Oncology. Oct 2013; 24: 2641-2645https://doi.org/10.1093/annonc/mdt299Abstract Full Text Full Text PDF PubMed Scopus (41) Google Scholar]. Consequently, numerous patients seek advice from family members, friends, or non-traditional healthcare practitioners [27Ucan O. Pehlivan S. Ovayolu N. Sevinc A. Camci C. The use of complementary therapies in cancer patients: a questionnaire-based descriptive survey from southeastern Turkey.American journal of clinical oncology. Dec 2008; 31: 589-594https://doi.org/10.1097/COC.0b013e31817700ccCrossref PubMed Scopus (20) Google Scholar]. Engaging in discussions with patients regarding TCAM usage can assist them in making informed decisions and minimizing potential side effects when using these therapies concurrently with conventional cancer medications [28Mwaka AD, Abbo C, Kinengyere AA. Traditional and complementary medicine use among adult cancer patients undergoing conventional treatment in Sub-Saharan Africa: a scoping review on the use, safety and risks. Cancer management and research. 2020:3699-3712.Google Scholar]. Physicians should therefore be well-informed about TCAM-induced side effects or interactions, recognize the associated risks, and advise patients against indiscriminate TCAM usage. Furthermore, patients should be encouraged to disclose their TCAM usage to their healthcare providers [29Werneke U. Earl J. Seydel C. Horn O. Crichton P. Fannon D. Potential health risks of complementary alternative medicines in cancer patients.British journal of cancer. Jan 26 2004; 90: 408-413https://doi.org/10.1038/sj.bjc.6601560Crossref PubMed Scopus (192) Google Scholar]. A significant challenge within TCAM is the absence of treatment protocols, standardization, and policy guidelines. Some TCAM methods concentrate on physical aspects of care, while others emphasize spiritual and mental aspects [30Ikram R.R.R. Abd Ghani M.K. Abdullah N. An analysis of application of health informatics in Traditional Medicine: A review of four Traditional Medicine Systems.International journal of medical informatics. 2015; 84: 988-996Crossref PubMed Google Scholar]. Despite TCAM's implementation in over 100 countries worldwide, as per the WHO Traditional Medicine Strategy 2014–2023 [31World Health Organization. WHO traditional medicine strategy: 2014-2023. World Health Organization; 2013.Google Scholar], the lack of treatment standards has hindered its progress and had a detrimental impact [32Lai T-Y, Tseng Y-T, Lee C-N. Physician and Consumer Acceptance of the Traditional Chinese Medicine Clinical Practice Support Sustem (TCMCPSS). 2014:321-327.Google Scholar]. Additionally, contradictory findings and potential herbal-drug interactions have impeded the establishment of universally accepted guidelines. Consequently, healthcare professionals often recommend abstaining from herbal products entirely during active anti-cancer treatments, a stance deemed by some as lacking principles [33Sparreboom A. Cox M.C. Acharya M.R. Figg W.D. Herbal remedies in the United States: potential adverse interactions with anticancer agents.Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Jun 15 2004; 22: 2489-2503https://doi.org/10.1200/jco.2004.08.182Crossref PubMed Scopus (0) Google Scholar]. However, this perspective may not be well-received by patients, their families, or society and may disrupt the physician-patient relationship [34Hardy M.L. Dietary supplement use in cancer care: help or harm.Hematology/oncology clinics of North America. Aug 2008; 22 (vii): 581-617https://doi.org/10.1016/j.hoc.2008.04.012Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar]. Furthermore, it may be considered an unethical approach that disregards patient autonomy [35Ben-Arye E. Attias S. Tadmor T. Schiff E. Herbs in hemato-oncological care: an evidence-based review of data on efficacy, safety, and drug interactions.Leukemia & lymphoma. Aug 2010; 51: 1414-1423https://doi.org/10.3109/10428194.2010.487622Crossref PubMed Scopus (24) Google Scholar]. Although specific TCAM regulations and directives have been instituted in some countries to streamline the procedures, there remains a need for the development and approval of further regulations regarding the authorities responsible for addressing related complaints and how non-specialists practicing TCAM are to be treated [36Taghipour A. Bahrami Taghanaki H. Hosienzade H. Noras M. Ethical and legal challenges in complementary and alternative medicine. Review.Iranian Journal of Medical Ethics and History of Medicine. 2016; 9: 23-31Google Scholar]. Challenges related to TCAM studies represent another significant obstacle. All TCAM treatment approaches share common features, including the use of complex interventions such as herbal remedies, individualized diagnosis and treatment, emphasis on the body's inherent healing capacity, and treating patients holistically, considering their physical and mental characteristics. Validating the effectiveness of TCAM methods requires the conduct of scientific research and the generation of sound evidence using appropriate methodologies. However, in many instances, conducting clinical trials poses considerable challenges. TCAM is not seamlessly integrated into the mainstream healthcare system, and the expenses associated with its treatments are added to the overall research costs. Comparing conventional treatments with TCAM methods often yields incomparable results, as many patient responses, particularly those related to spiritual changes following these treatments, are challenging to quantify. Ethical dilemmas in clinical trials, as well as issues with randomization and blinding methods, alongside the absence of long-term patient follow-ups, present additional hurdles [37Yang Y. Tian K. Bai G. et al.Health technology assessment in traditional Chinese medicine in China: current status, opportunities, and challenges.Global Health Journal. 2019; 3 (2019/12/01/): 89-93https://doi.org/10.1016/j.glohj.2019.11.002Crossref Scopus (13) Google Scholar]. Uncertainty regarding research costs in TCAM medicine, challenges within research centers, the lack of support and incentive packages for traditional medicine research in certain countries, and the abundance of keywords linked to TCAM represent further research challenges in this field [38Kenu A. Kenu E. Bandoh D.A. Aikins M. Factors that promote and sustain the use of traditional, complementary and integrative medicine services at LEKMA hospital, an complementary medicine and Jan PubMed Scopus (3) Google Scholar]. In numerous countries, herbal medicines and related products are to the without undergoing safety or is a lack of regulations methods and quality Herbal products, and from and to easily the M.M. Tan issues on used herbal products, herbal medicines and in the of Association of of Scholar]. Some herbal products on the may be of quality and efficacy, yet they are often without the of potential risks associated with their use C. Integration of traditional and complementary medicine in to evidence-based clinical practice. Scholar]. Challenges in this include the popularity of natural remedies for herbal products as anticancer remedies a lack of and beliefs to M. complementary and alternative medicine in the conventional treatment of cancer patients: analysis of a clinical of medical and of medicine. 14: PubMed Scopus (0) Google Scholar]. that in many countries, TCAM independently from healthcare it often monitoring by the safety mechanisms and systems established within the and legal [15World Health Organization. National policy on traditional medicine and regulation of herbal medicines: Report of a WHO global survey. World Health Organization; 2005.Google Scholar]. medicine has the field of traditional medicine its in many countries and has in is only natural with the in traditional medicine among the centers traditional medicine services should a more in disease and treatment, by an enhanced of and the challenges associated with the use and of traditional medicine into the healthcare system, it is to the of these be In various worldwide, particularly in and countries, TCAM as a of healthcare Health Organization. of Traditional Medicine and Medicine: A Scholar]. many this medical approach is in their and constitutes a of healthcare Health Organization. on the of Traditional Medicine in Primary Health Scholar]. In certain instances, it may be the or healthcare in and N. Smith L. Health in and the of the Traditional healthcare in of Health Management. Scopus Google Scholar]. The of the of including the of traditional medicine in the of health for A. of on health Scholar]. numerous and have been established to the of traditional medicine into healthcare as a to Health Integrating traditional and complementary medicine with healthcare systems for health in and the & 2019; PubMed Scopus Google Scholar]. The of TCAM within healthcare systems has as a and S. et for of health care policy in from the perspective of and of integrative medicine. 2017; PubMed Google Scholar]. The World Health Organization (WHO) of and healthcare In the integrative TCAM is and into aspects of healthcare as in countries like the of and The healthcare TCAM as an of medical it may not be fully integrated into aspects of healthcare and following this approach include and in the healthcare system, certain TCAM methods are accepted [31World Health Organization. WHO traditional medicine strategy: 2014-2023. World Health Organization; 2013.Google S. E. and of traditional medicine in A of Research 2010; Scholar]. on training in the field of TCAM represents one of the most significant TCAM is on the global with the World Health Organization (WHO) it due to WHO training is in countries worldwide, while countries have instituted training to in complementary medicine and medical Health Organization. WHO global on traditional and complementary medicine World Health Organization; Scholar]. In this is the establishment of medical research centers, and new health Additionally, the of the Traditional and Complementary Medicine has been established within the of in conjunction with and medical centers within the of complementary medicine, or not S. A. with in the of A of Complementary and Alternative Medicine of and Research in Google Scholar]. Integrative as a and a centers on the health of cancer patients. approaches to conventional treatments such as treatments, and The is to principles and for complementary medicine interventions that are and for patients, healthcare and at The integrative oncology for patient care and oncology Aug 2008; PubMed Google Scholar]. TCAM complementary methods that have the potential to enhance quality of their and or mitigate side effects, it is integrated with conventional cancer The challenges associated with TCAM usage in cancer care should not of conventional medicine to TCAM as a in cancer care, particularly within the of and In many instances, the of these services are including their cost-effectiveness, with cultural belief patient with and with the current healthcare on opportunities, it is to these challenges and the
No AccessStand Alone Books1 Feb 2013A Conservation Assessment of the Terrestrial Ecoregions of Latin America and the CaribbeanAuthors/Editors: Eric Dinerstein, David M. Olson, Douglas J. Graham, Avis L. Webster, Steven A. Primm, Marnie P. Bookbinder, George Ledec, World Wildlife FundEric Dinerstein, David M. Olson, Douglas J. Graham, Avis L. Webster, Steven A. Primm, Marnie P. Bookbinder, George Ledec, World Wildlife Fundhttps://doi.org/10.1596/0-8213-3295-3SectionsAboutPDF (6.5 MB) ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookTwitterLinked In Abstract:This priority-setting study elevates, as a first principle, maintaining the representation of all ecosystem and habitat types in regional investment portfolios. Second, it recognizes landscape-level features as an essential guide for effective conservation planning. Without an objective framework to assess the conservation status and biological distinctiveness of geographic areas, donors run the risk of overlooking areas that are seriously threatened and of greatest biodiversity value. The lack of such an objective regional framework prompted this study, whose goals were: 1) to replace the relatively ad hoc decisionmaking process of donors investing in biodiversity conservation with a more transparent and scientific approach; 2) to move beyond evaluations based largely on species lists to a new framework that also incorporates maintaining ecosystems and habitat diversity; 3) to better integrate the principles of conservation biology and landscape ecology into decisionmaking; and 4) to ensure that proportionately more funding be channeled to areas that are of high biological value and under serious threat. FiguresreferencesRecommendeddetailsCited byOn the presence of Alsodes coppingeri (Anura, Alsodidae) in Argentina, with comments on other southern AlsodesNeotropical Biodiversity, Vol.8, No.127 February 2022Geographic distribution patterns of amphibians and reptiles from the Uruguayan SavannaSystematics and Biodiversity, Vol.20, No.114 March 2022Beyond Carbon: The Contributions of South American Tropical Humid and Subhumid Forests to Ecosystem ServicesReviews of Geophysics, Vol.60, No.429 September 2022Rural livelihood diversification is associated with lower vulnerability to climate change in the Andean-Amazon foothillsPLOS Climate, Vol.1, No.118 November 2022Neglected plant parasites: MitrastemonaceaePLANTS, PEOPLE, PLANET, Vol.1475 September 2022Genetic divergence and demography of pudu deer (Pudu puda) in five provinces of southern Chile, analyzed through latitudinal and longitudinal rangesNeotropical Biology and Conservation, Vol.17, No.221 June 2022Sharing the Space: Variation in Morphometric, Ecoregional, Migratory and Reproductive Patterns of Three Sympatric Artibeus SpeciesActa Chiropterologica, Vol.24, No.1Bioclimatic changes in ecoregions of southern South America: Trends and projections based on Holdridge life zonesAustral Ecology, Vol.47, No.330 December 2021Above-ground biomass and high temperatures are more important than productivity for the spatial pattern of bird richness in Subtropical Dry forests of ArgentinaCommunity Ecology, Vol.23, No.111 January 2022Inventario florístico en áreas de bosque andino de la cordillera central de Colombia (El Peñol, Antioquia)Caldasia, Vol.44, No.17 March 2022Climatic and soil factors explain the two-dimensional spectrum of global plant trait variationNature Ecology & Evolution, Vol.6, No.123 December 2021Climate Change Effects, Adaptation, and Mitigation Techniques in Tropical Dry ForestsToward a terrestrial biogeographical regionalisation of the world: historical notes, characterisation and area nomenclatureAustralian Systematic Botany, Vol.35, No.34 July 2022Taxonomy, Distribution, and Conservation Status of Wild Guanaco Populations17 August 2022Global assessment and mapping of ecological vulnerability to wildfiresNatural Hazards and Earth System Sciences, Vol.22, No.99 September 2022Waterbird assemblages of inland wetlands in Chile: A meta-analysisNature Conservation, Vol.4515 December 2021Amphibians of the equatorial seasonally dry forests of Ecuador and PeruZooKeys, Vol.106318 October 2021A novel biome concept and classification system based on bioclimate and vegetation – a Neotropical assayVegetation Classification and Survey, Vol.27 October 2021Tree-Holes as Alternative Reproductive Sites of Batrachyla antartandica Barrio, 1967 (Anura: Batrachylidae)South American Journal of Herpetology, Vol.20, No.1Patterns of ecosystem functioning as tool for biological regionalization: the case of the Mediterranean-desert-tropical transition of Baja CaliforniaMediterranean Botany, Vol.4227 October 2021Flora y Vegetación de la Reserva de la Biosfera Zicuirán-Infiernillo, Michoacán, MéxicoBotanical Sciences, Vol.99, No.327 April 2021Environmental Seasonality Explains Reproductive Timing of Short-Tailed Fruit Bats in a Premontane Forest of Central PeruActa Chiropterologica, Vol.23, No.1Patterns of host tree use within a lineage of saproxlic snout-less weevils (Coleoptera: Curculionidae: Scolytinae: Scolytini)Molecular Phylogenetics and Evolution, Vol.159A new species group of Strumigenys (Hymenoptera, Formicidae) from Ecuador, with a description of its mandible morphologyZooKeys, Vol.10365 May 2021An investigation on the human impact intensity on the selected ecoregions of coastal areas of Hormozgan Province, Persian Gulf, Strait of Hormuz, South of IranEnvironment, Development and Sustainability, Vol.23, No.418 June 2020Remnants of native forests support carnivore diversity in the vineyard landscapes of central ChileOryx, Vol.55, No.230 January 2020Estimating genetic diversity, mating system and pollen dispersal to inform ex situ conservation of the tree Genipa americana L.Plant Genetic Resources: Characterization and Utilization, Vol.19, No.11 March 2021Biogeographic regionalisation of the Baja California biogeographic province, Mexico: A reviewJournal of Natural History, Vol.55, No.5-611 June 2021Colonization of different biomes drove the diversification of the Neotropical Eidmanacris crickets (Insecta: Orthoptera: Grylloidea: Phalangopsidae)PLOS ONE, Vol.16, No.115 January 2021Ecology and Conservation of the World's Primates25 November 2020Mapping and assessing ecosystems and their services: a comparative approach to ecosystem service supply in Suriname and French GuianaEcosystems and People, Vol.17, No.126 March 2021Selective consumption of rodents by the Variable hawk Geranoaetus polyosoma (Accipitriformes: Accipitridae) in the Atacama Desert, northern ChileZoologia, Vol.377 December 2020Defining intraspecific conservation units in the endemic Cuban Rock Iguanas (Cyclura nubila nubila)Scientific Reports, Vol.10, No.110 December 2020Predictive Habitat Model Reveals Specificity in a Broadly Distributed Forest Raptor, The Harpy EagleJournal of Raptor Research, Vol.54, No.4Resistencias urbanas al cambio climático: Consumo crítico, agroecología y defensa del territorio en Guadalajara, Jalisco, México.Agua y Territorio, No.1617 November 2020Leaf Litter Decomposition in Diverse Silvopastoral Systems in a Neotropical EnvironmentJournal of Sustainable Forestry, Vol.39, No.79 February 2020Seasonal patterns of ecological uniqueness of anuran metacommunities along different ecoregions in Western BrazilPLOS ONE, Vol.15, No.924 September 2020The Effect of Anthropization on Sarcophagidae (Diptera: Calyptratae) Community Structure: An Assessment on Different Types of Habitats in the Humid Chaco Ecoregion of ArgentinaJournal of Medical Entomology, Vol.57, No.520 April 2020Composition and changes in the spontaneous flora of the Wadi El Rayan Ramsar site, Fayoum, Egypt, in the last 20 yearsLimnological Review, Vol.20, No.38 October 2020People and jaguars: new insights into the role of social factors in an old conflictOryx, Vol.54, No.517 January 2020Distribution modelling of the Pudu deer (Pudu puda) in southern ChileNature Conservation, Vol.4128 August 2020A new Terrarana frog of genus Pristimantis from an unexplored cloud forest from the eastern Andes, ColombiaZooKeys, Vol.96119 August 2020Action needed for staple crops in the Andean-Amazon foothills because of climate changeMitigation and Adaptation Strategies for Global Change, Vol.25, No.630 June 2020Odontomachus davidsoni sp. nov. (Hymenoptera, Formicidae), a new conspicuous trap-jaw ant from EcuadorZooKeys, Vol.94813 July 2020Flowers are essential to maintain high beetle diversity (Coleoptera) in a Neotropical rainforest canopyJournal of Natural History, Vol.54, No.25-2618 November 2020Responses of anuran diversity to wetland characteristics and surrounding landscape in the Southern Andean Yungas, ArgentinaAquatic Conservation: Marine and Freshwater Ecosystems, Vol.30, No.710 June 2020Molecular phylogeny of Cremolobus (Brassicaceae) supports the recognition of the new genus Yunkia and demonstrates the high habitat diversity of tribe CremolobeaeSystematics and Biodiversity, Vol.18, No.37 May 2020Campesino hunting and conservation in Latin AmericaConservation Biology, Vol.34, No.219 September 2019Biogeographic Regionalization of the Mexican Transition Zone2 July 2020Ecology and Conservation of the World's Primates11 June 2020The Diversification of Organized Crime into Gold Mining: Domination, Crime Convergence, and Ecocide in Darién, Colombia6 October 2020Conservation Concerns About the Southernmost Lizards of the World24 August 2020Behavior, Diet, and Habitat Use by Blonde Capuchin Monkeys (Sapajus flavius) in a Coastal Area Prone to Flooding: Direct Observations and Camera TrappingInternational Journal of Primatology, Vol.40, No.4-53 September 2019Expansion of the agricultural frontier in the largest South American Dry Forest: Identifying priority conservation areas for snakes before everything is lostPLOS ONE, Vol.14, No.910 September 2019Influence of environmental variables and human activities on the seasonal habitat use by guanacos in Southern Andean Precordillera (Argentina)Studies on Neotropical Fauna and Environment, Vol.54, No.32 September 2019Revisión Sistemática del Estado del conocimiento de los Vertebrados del Parque Nacional PodocarpusLa Granja, Vol.30, No.231 August 2019The butterflies of a Cerrado–Atlantic Forest ecotone at Laguna Blanca reveal underestimation of Paraguayan butterfly diversity and need for conservationJournal of Insect Conservation, Vol.23, No.42 July 2019Hidden areas of endemism: Small units in the South-eastern NeotropicsSystematics and Biodiversity, Vol.17, No.515 August 2019Diversity and distributional patterns of aroids (Alismatales: Araceae) along an elevational gradient in Darién, PanamaWebbia, Vol.74, No.228 August 2019Investigating the geomorphic characteristics of an Amazonian headwater stream draining a páramo ecosystemPhysical Geography, Vol.40, No.230 August 2018Composition and Host-Use Patterns of a Scarab Beetle (Coleoptera: Scarabaeidae) Community Inhabiting the Canopy of a Lowland Tropical Rainforest in Southern VenezuelaThe Coleopterists Bulletin, Vol.73, No.1Primates in Flooded Habitats, Vol.2024 December 2018Angola in Outline: Physiography, Climate and Patterns of Biodiversity21 February 2019A new frog of the Leptodactylus fuscus species group (Anura: Leptodactylidae), endemic from the South American Gran ChacoPeerJ, Vol.711 October 2019ZooKeys, Vol.884Overview of Mitaraka survey: research frame, study site and field protocolsZoosystema, Vol.40, No.sp1Remotely-sensed productivity clusters capture global biodiversity patternsScientific Reports, Vol.8, No.12 November 2018The Definition of Bioregions in Palaeontological Studies of Diversity and Biogeography Affects Interpretations: Palaeozoic Tetrapods as a Case StudyFrontiers in Earth Science, Vol.614 November 2018Characterization of forest carbon stocks at the landscape scale in the Argentine Dry ChacoForest Ecology and Management, Vol.424Genetic structuring in a Neotropical palm analyzed through an Andean orogenesis‐scenarioEcology and Evolution, Vol.8, No.1620 July 2018Geographical ecology of dry forest tree communities in the West IndiesJournal of Biogeography, Vol.45, No.57 March 2018Real-time DNA barcoding in a rainforest using nanopore sequencing: opportunities for rapid biodiversity assessments and local capacity buildingGigaScience, Vol.7, No.42 April 2018Density, habitat use, and activity patterns of a vulnerable population of the Solitary Tinamou ( Tinamus solitarius ) in a Brazilian Atlantic Forest fragmentCanadian Journal of Zoology, Vol.96, No.3Comparison of African and North American velvet ant mimicry complexes: Another example of Africa as the 'odd man out'PLOS ONE, Vol.13, No.13 January 2018Management Methods and Demonstration on Pollution Load Control of Song-Liao River Basin17 May 2018A tripartite survey of hyperparasitic fungi associated with ectoparasitic flies on bats (Mammalia: Chiroptera) in a neotropical cloud forest in PanamaParasite, Vol.2510 April 2018Diet, dietary selectivity and density of South American grey fox, Lycalopex griseus , in Central ChileIntegrative Zoology, Vol.13, No.1Spatially explicit modelling of the impacts of land-use and land-cover change on nutrient inputs to an oligotrophic lakeInternational Journal of Remote Sensing, Vol.38, No.2418 June 2017Private protected areas, ecotourism development and impacts on local people's well-being: a review from case studies in Southern ChileJournal of Sustainable Tourism, Vol.25, No.1227 May 2016Origin and cross-century dynamics of an avian hybrid zoneBMC Evolutionary Biology, Vol.17, No.115 December 2017Feathered Roots and Migratory Routes: Immigrants and Birds in the AnthropoceneNature and Culture, Vol.12, No.3Urbanization impacts on the trophic guild composition of bird communitiesJournal of Natural History, Vol.51, No.39-4015 September 2017River Conservation in Venezuela: A ReviewJournal of Aquaculture & Marine Biology, Vol.5, No.13 January 2017The Trifinio Region: a case study of transboundary forest change in Central AmericaJournal of Land Use Science, Vol.12, No.19 December 2016PeerJ, Vol.5Scientific Reports, Vol.7, No.1Correspondence between the habitat of the threatened pudú (Cervidae) and the national protected-area system of ChileBMC Ecology, Vol.16, No.17 January 2016A MONOGRAPHIC REVISION OF RETROPHYLLUM (PODOCARPACEAE)Edinburgh Journal of Botany, Vol.73, No.222 June 2016Growth of native tree species planted in montane reforestation projects in the Colombian and Ecuadorian Andes differs among site and speciesNew Forests, Vol.47, No.312 November 2015Genetic diversity in the Neotropical river otter, Lontra longicaudis (Mammalia, Mustelidae), in the Lower Delta of Parana River, Argentina and its relation with habitat suitabilityHydrobiologia, Vol.768, No.131 October 2015Creating Protected Areas on Public Lands: Is There Room for Additional Conservation?PLOS ONE, Vol.11, No.25 February 2016Firewood supply and consumption in the context of agrarian change: the Northern Argentine Chaco from 1990 to 2010International Journal of the Commons, Vol.10, No.11 February 2016Above-Ground Biomass, Nutrients and Carbon in Aegiceras corniculatum of the SundarbansOpen Journal of Forestry, Vol.06, No.02Species conservation importance index (SCI) for comparing sites' conservation value at landscape levelBrazilian Journal of Botany, Vol.38, No.413 August 2015Multi-dimensionality and variability in folk classification of stingless bees (Apidae: Meliponini)Journal of Ethnobiology and Ethnomedicine, Vol.11, No.123 May 2015Spatial incongruence among hotspots and complementary areas of tree diversity in southern AfricaDiversity and Distributions, Vol.21, No.718 December 2014Disentangling the effects of shrubs and herbivores on tree regeneration in a dry Chaco forest (Argentina)Oecologia, Vol.178, No.325 February 2015A MONOGRAPHIC REVISION OF THE GENUS PODOCARPUS (PODOCARPACEAE): III. THE SPECIES OF THE CENTRAL AMERICA AND NORTHERN MEXICO BIOREGIONSEdinburgh Journal of Botany, Vol.72, No.21 July 2015Native forest replacement by exotic plantations in southern Chile (1985?2011) and partial compensation by natural regenerationForest Ecology and Management, Vol.345Demographic Structure and Evolutionary History of Drosophila ornatifrons (Diptera, Drosophilidae) from Atlantic Forest of Southern BrazilZoological Science, Vol.32, No.2A MONOGRAPHIC REVISION OF THE GENUS PODOCARPUS (PODOCARPACEAE): II. THE SPECIES OF THE CARIBBEAN BIOREGIONEdinburgh Journal of Botany, Vol.72, No.119 February 2015Designing Transboundary Conservation: Navigating Sovereignty and Ecosystem Scale in the Guiana ShieldInternational Studies Perspectives27 February 2015Structure of Dung Beetle Communities in an Altitudinal Gradient of Neotropical Dry ForestNeotropical Entomology, Vol.44, No.115 January 2015Loss of mammalian species from the South American Gran Chaco: empty savanna syndrome?Mammal Review, Vol.45, No.125 November 2014A MONOGRAPHIC REVISION OF THE GENUS PODOCARPUS (PODOCARPACEAE): I. HISTORICAL REVIEWEdinburgh Journal of Botany, Vol.71, No.37 November 2014Insects of French Guiana: a baseline for diversity and taxonomic effortZooKeys, Vol.43414 August 2014Land-use and land-cover effects on regional biodiversity distribution in a subtropical dry forest: a hierarchical integrative multi-taxa studyRegional Environmental Change, Vol.14, No.411 March 2014A Cluster Randomized Controlled Trial to Reduce Childhood Diarrhea Using Hollow Fiber Water Filter and/or Hygiene–Sanitation Educational InterventionsThe American Journal of Tropical Medicine and Hygiene, Vol.91, No.1Biodiversity and biomass of a natural and degraded mangrove forest of Peninsular MalaysiaEnvironmental Earth Sciences, Vol.71, No.1115 October 2013Improved heat tolerance in air drives the recurrent evolution of air-breathingProceedings of the Royal Society B: Biological Sciences, Vol.281, No.17827 May 2014Pest management through tropical tree conservationBiodiversity and Conservation, Vol.23, No.41 February 2014Avian species composition across the Amazon River: the roles of dispersal limitation and environmental heterogeneityJournal of Biogeography, Vol.41, No.44 December 2013The Archaeology of Cosmic Impact: Lessons from Two Mid-Holocene Argentine Case StudiesJournal of Archaeological Method and Theory, Vol.21, No.115 September 2012Amphibian Diversity and Species Composition in Relation to Habitat Type and Alteration in the Mache–Chindul Reserve, Northwest EcuadorHerpetologica, Vol.70, No.1Analysis of anthropogenic impacts on forest biodiversity as a contribution to empirical theoryNovel Yeast Strains from Brazilian Biodiversity: Biotechnological Applications in Lignocellulose Conversion into Biofuels3 April 2014Regional patterns and controls of biomass in semiarid woodlands: lessons from the Northern Argentina Dry ChacoRegional Environmental Change, Vol.13, No.63 March 2013Refugia in Patagonian fjords and the eastern Andes during the Last Glacial Maximum revealed by huemul ( Hippocamelus bisulcus ) patterns and genetic of Biogeography, Vol.40, August of Amazonian in a threatened and Conservation, Vol.22, August tropical forest types as support for the of biodiversity under Management, April are habitat for Conservation, for conservation by Ecology, Vol.38, June Scale of as of the of Environmental to Community Vol.45, November of diversification in the high Andean Entomology, Vol.38, January of ( ) in El Zoology, Vol.8, April of Change on Water in Andean of the of American of the Andean high on the and population of ( ) in South Ecology, Vol.22, December for – a Conservation, December protected areas of Mexico: ecological and conservation across Journal of Science, is in the and of in the endemic tree Conservation, of of the of January of a Neotropical ecosystem the No.12 December of composition in Amazonian of Biogeography, Vol.38, August of terrestrial ecosystems in protected area Conservation, Vol.38, May tree of for the River in central Research, Vol.47, No.630 June to intensity of in Conservation, March April and social for the of a Andean cloud forest: and lessons from a case study in northern in the forest of northern for the use of cloud forest montane cloud of and in a of the Brazilian A of No.325 March of Tropical Dry Case May of Chile and in South May habitat management and its on the biological of the Journal of Wildlife Research, No.520 March and of the genus (Hymenoptera, with biogeographic for the South American Entomology, Vol.35, February of a approach to the de and and Conservation, Vol.19, February of World Wildlife for ecoregions and for conservation in Neotropical biodiversity Conservation, June vegetation be based on plant Ecology, No.125 August of threatened in the river Conservation Vol.20, October a for Conservation August conservation de la de in of Forest in an Management, Vol.44, No.411 August and conservation status of ( of and Biological into Global Conservation for ONE, August structuring the in the Atlantic Forest of Ecology, Vol.34, Neotropical ecoregions for conservation of terrestrial and Conservation, Vol.18, January of historical of in southern and Conservation, Vol.18, December conservation assessment for the and Tropical Andes biodiversity a and Conservation, Vol.18, December and associated of native in Northern Patagonian Biology, Vol.54, and by in the dry Chaco of of the April dry forests in Venezuela: assessing and Conservation, Vol.35, February of Neotropical under different mapping species to conservation and Distributions, Vol.14, and use of in species of in the Atlantic Forest of Ecology, and for global biodiversity for the of the global of protected and Distributions, Vol.14, December Ecoregions of the A of for Freshwater May comparative of biodiversity based on species and Conservation, Vol.17, January and the of and in the of No.119 February of the River in the Rainforest Change, July and biogeographical on and Andean species using genetic of Ecology, Vol.17, January ecological and the in Ecology and the Environment, Vol.5, biodiversity and protected and Conservation, Vol.16, March of Conservation using An for the of South and Conservation, Vol.16, October are the effective for conservation among Brazilian and Distributions, Vol.13, March and a status assessment of a deer from the montane forests of of Zoology, No.413 September are Andean montane forest bird communities to habitat and Conservation, Vol.16, October and environmental framework and February dynamics in the for of the Royal Society B: Biological Sciences, December and livelihood diversity in eastern and Vol.24, January assessment of tree communities in the northern of Ecology, January and population of the Ecology, Vol.16, December of Conservation: to and Biology, Vol.21, risk in the of for terrestrial and Conservation, Vol.16, No.127 October of Journal of the May of a assessment of the and biodiversity impacts of Management, Vol.21, August to stream in southern between geographic and October and of – An in Central and Conservation, Vol.15, July of Forests in Mexico: The Ecology of a of the of American Vol.96,
No AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Dec 2002A Prospective Study Comparing Paroxetine Alone Versus Paroxetine Plus Sildenafil in Patients With Premature Ejaculation ANDREA SALONIA, TOMMASO MAGA, RENZO COLOMBO, VINCENZO SCATTONI, ALBERTO BRIGANTI, ANDREA CESTARI, GIORGIO GUAZZONI, PATRIZIO RIGATTI, and FRANCESCO MONTORSI ANDREA SALONIAANDREA SALONIA , TOMMASO MAGATOMMASO MAGA , RENZO COLOMBORENZO COLOMBO , VINCENZO SCATTONIVINCENZO SCATTONI , ALBERTO BRIGANTIALBERTO BRIGANTI , ANDREA CESTARIANDREA CESTARI , GIORGIO GUAZZONIGIORGIO GUAZZONI , PATRIZIO RIGATTIPATRIZIO RIGATTI , and FRANCESCO MONTORSIFRANCESCO MONTORSI View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)64174-2AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We compared the efficacy of paroxetine alone and combined with sildenafil in patients complaining of premature ejaculation. Materials and Methods: Enrolled in this study were 80 consecutive potent men 19 to 47 years old (mean age 34) with premature ejaculation but without any obvious organic cause. Pretreatment evaluation included a history, self-administration of the International Index of Erectile Function (IIEF) questionnaire, physical examination and the Meares-Stamey test to exclude genital tract infection. The initial 40 patients received 10 mg. paroxetine daily for 21 days and then 20 mg. as needed, that is 3 to 4 hours before planned sexual activity, for 6 months (group 1). The other group of 40 men received 10 mg. paroxetine daily for 21 days and then 20 mg. as needed plus 50 mg. sildenafil as needed, that is 1 hour before planned sexual activity, for 6 months (group 2). Patients were followed 3 and 6 months after beginning therapy and were evaluated using several general assessment questions, IIEF and ejaculatory latency time. Results: Mean ejaculatory latency time ± SE in group 1 was 0.33 ± 0.04, 3.7 ± 0.10 (p <0.01) and 4.2 ± 0.03 (p <0.01) minutes at baseline, 3 and 6-month followup, while in group 2 it was 0.35 ± 0.03, 4.5 ± 0.07 (p <0.01) and 5.3 ± 0.02 (p <0.001) minutes, respectively. When improvement in ejaculatory latency time was compared in the 2 groups, group 2 results proved to be significantly greater (p <0.05). Baseline, and 3 and 6-month mean intercourse satisfaction domain values of the IIEF were 9, 11 and 11 (p = 0.09, not significant), and 9, 11 and 14 (p <0.05) in groups 1 and 2, respectively. Group 2 patients reported significantly greater intercourse satisfaction than those in group 1 (p <0.05). At baseline, 3 and 6 months there was a mean of 0.9 ± 0.1, 1.7 ± 0.3 (not significant) and 2.5 ± 0.3 (p <0.01) coitus episodes weekly in group 1, and 1 ± 0.2, 2.3 ± 0.3 (p <0.01) and 3.2 ± 0.1 (p <0.001) in group 2, respectively. Group 2 patients reported a significantly higher number of coitus episodes weekly (p <0.05). Side effects in the 40 group 1 cases included anejaculation in 1 (2.5%), gastrointestinal upset and/or nausea in 5 (12.5%), headache in 4 (10%) and decreased libido in 2 (5%). Side effects in the 40 group 2 cases included anejaculation in 1 (2.5%), headache in 8 (20%), gastrointestinal upset and/or nausea in 6 (15%) and flushing in 6 (15%). Group 2 patients reported significantly more headaches (p <0.01) and flushing episodes (p <0.001) than those in group 1. After 6 months of treatment 33 men (82.5%) in group 1 and 36 (90%) in group 2 were willing to continue therapy (not significant). Conclusions: Paroxetine combined with sildenafil appears to provide significantly better results in terms of ejaculatory latency time and intercourse satisfaction versus paroxetine alone in potent patients with premature ejaculation. However, combined treatment is associated with a mild increase in drug related side effects. References 1 : Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. J Public Health Med1997; 19: 387. Crossref, Medline, Google Scholar 2 : Sexual dysfunction in the United States: prevalence and predictors. JAMA1999; 281: 537. Crossref, Medline, Google Scholar 3 Diagnostic and Statistical Manual of Mental Disorders, DSM-IV. Washington, D.C.: American Psychiatric Association1994: 509. Google Scholar 4 : Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies. J Urol1999; 161: 1826. Link, Google Scholar 5 : Ejaculatory dysfunction. BJU Int1999; 83: 557. Crossref, Medline, Google Scholar 6 : Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol1999; 19: 67. Crossref, Medline, Google Scholar 7 : Treatment-emergent sexual dysfunction in affective disorder: a review and management strategies. J Clin Psychiatr Monogr1993; 11: 57. Google Scholar 8 : The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study. J Urol1996; 156: 1631. Link, Google Scholar 9 : Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study. J Urol1998; 159: 1935. Link, Google Scholar 10 : Paroxetine in the treatment of premature ejaculation. Br J Urol1996; 77: 881. Crossref, Medline, Google Scholar 11 : Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med1998; 338: 1397. Crossref, Medline, Google Scholar 12 : Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction. J Urol2000; 164: 1192. Link, Google Scholar 13 : Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res2001; 13: 41. Crossref, Medline, Google Scholar 14 : The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology1997; 49: 822. Crossref, Medline, Google Scholar 15 : Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology1999; 54: 346. Crossref, Medline, Google Scholar 16 : Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study. Br J Urol1997; 79: 592. Crossref, Medline, Google Scholar 17 : A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatr Scand1991; 80: 60. Crossref, Google Scholar 18 : The roles of nitric oxide in sexual function of male rats. Neuropharmacology1994; 33: 1499. Crossref, Medline, Google Scholar 19 : Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS−/−). Physiol Behav1999; 67: 561. Crossref, Medline, Google Scholar 20 : Effects of various nitric oxide donating agents on the contractility and cyclic nucleotide turnover of human seminal vesicles in vitro. Urology2002; 59: 958. Crossref, Medline, Google Scholar 21 : A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction, incidence, possible aetiology and implications for management. J Psychopharmacol1997; 11: 72. Crossref, Medline, Google Scholar 22 : The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes. Br J Clin Pharmacol1992; 33: 521. Crossref, Medline, Google Scholar 23 : Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil. Br J Clin Pharmacol2001; 51: 239. Crossref, Medline, Google Scholar From the Department of Urology, University "Vita-Salute" School of Medicine, Scientific Institute H. San Raffaele, Milan, Italy© 2002 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited by Abdel-Hamid I, Abo-Aly M and Mostafa T (2023) Phosphodiesterase type 5 inhibitors and premature ejaculation: an overview of systematic reviews/meta-analyses using the AMSTAR 2, ROBIS, and GRADE toolsSexual Medicine Reviews, 10.1093/sxmrev/qeac003, VOL. 11, NO. 1, (23-51), Online publication date: 19-Jan-2023. Mitsogiannis I, Dellis A, Papatsoris A and Moussa M (2022) An up-to-date overview of the pharmacotherapeutic options for premature ejaculationExpert Opinion on Pharmacotherapy, 10.1080/14656566.2022.2035361, VOL. 23, NO. 9, (1043-1050), Online publication date: 13-Jun-2022. Zhou Z, Yang Z, Cui Y, Zhang X, Wang Y and Zhang Y (2022) The network meta‐analysis of "on‐demand" and "daily" use of paroxetine in treating men with premature ejaculation from randomized controlled trialsAndrologia, 10.1111/and.14388, VOL. 54, NO. 5, Online publication date: 1-Jun-2022. Mohamed Gharib T, Abdel-Al I, Elatreisy A, Kandeel W, El-Shaer W, Abdrabuh A, Mohamed Salih E and Sebaey A (2022) Short- and long-term follow-up results of daily 5-mg tadalafil as a treatment for erectile dysfunction and premature ejaculationArab Journal of Urology, 10.1080/2090598X.2021.2024695, VOL. 20, NO. 1, (49-53), Online publication date: 2-Jan-2022. Saleh R, Majzoub A and Abu El-Hamd M (2021) An update on the treatment of premature ejaculation: A systematic reviewArab Journal of Urology, 10.1080/2090598X.2021.1943273, VOL. 19, NO. 3, (281-302), Online publication date: 3-Jul-2021. Raheem O, Adnan M and Alzweri L (2021) Surgical and Nonsurgical Sperm Retrieval Techniques in Patients with Ejaculatory Dysfunctions Manual of Sperm Retrieval and Preparation in Human Assisted Reproduction, 10.1017/9781108867245.008, (44-55) Struck J (2021) Ejakulationsstörungen (Ejaculatio praecox) Medikamente in der Urologie, 10.1007/978-3-662-61492-1_16, (287-313), . Cai Z, Song X, Zhang J, Yang B and Li H (2020) Practical Approaches to Treat ED in PDE5i NonrespondersAging and disease, 10.14336/AD.2019.1028, VOL. 11, NO. 5, (1202), . Qin Z, Wang Y, Zhu J, Zhu K, Li R, Zhang L, Meng X, Xia J, Wang W, Qin C, Zhang W, Song N and Wang Z (2019) Safety and efficacy characteristics of oral drugs in patients with premature ejaculation: a Bayesian network meta-analysis of randomized controlled trialsInternational Journal of Impotence Research, 10.1038/s41443-019-0146-7, VOL. 31, NO. 5, (356-368), Online publication date: 1-Sep-2019. Tuken M, Culha M and Serefoglu E (2019) Efficacy and safety of dapoxetine/sildenafil combination tablets in the treatment of men with premature ejaculation and concomitant erectile dysfunction—DAP-SPEED StudyInternational Journal of Impotence Research, 10.1038/s41443-019-0122-2, VOL. 31, NO. 2, (92-96), Online publication date: 1-Mar-2019. Jin K, Deng L, Qiu S, Tu X, Li J, Bao Y, Yang L and Wei Q (2018) Comparative efficacy and safety of phosphodiesterase-5 inhibitors with selective serotonin reuptake inhibitors in men with premature ejaculationMedicine, 10.1097/MD.0000000000013342, VOL. 97, NO. 49, (e13342), Online publication date: 1-Dec-2018. Sridharan K, Sivaramakrishnan G, Sequeira R and Al-Khaja K (2018) Pharmacological interventions for premature ejaculation: a mixed-treatment comparison network meta-analysis of randomized clinical trialsInternational Journal of Impotence Research, 10.1038/s41443-018-0030-x, VOL. 30, NO. 5, (215-223), Online publication date: 1-Oct-2018. Sun Y, Yang L, Bao Y, Liu Z, Liu L and Wei Q (2017) Efficacy of PDE5Is and SSRIs in men with premature ejaculation: a new systematic review and five meta-analysesWorld Journal of Urology, 10.1007/s00345-017-2086-5, VOL. 35, NO. 12, (1817-1831), Online publication date: 1-Dec-2017. Knihavko O (2017) Results of Gel Implantation of Hyaluronic Acid under Mucous Balanus for Treatment of Early EjaculationUkraïnsʹkij žurnal medicini, bìologìï ta sportu, 10.26693/jmbs02.03.065, VOL. 2, NO. 3, (65-70), Online publication date: 31-Aug-2017. Karabakan M, Keskin E, Akdemir S and Bozkurt A (2017) Effect of tadalafil 5mg daily treatment on the ejaculatory times, lower urinary tract symptoms and erectile function in patients with erectile dysfunctionInternational braz j urol, 10.1590/s1677-5538.ibju.2016.0376, VOL. 43, NO. 2, (317-324), Online publication date: 1-Apr-2017. Martyn-St James M, Cooper K, Ren S, Kaltenthaler E, Dickinson K, Cantrell A, Wylie K, Frodsham L and Hood C (2017) Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysisEuropean Urology Focus, 10.1016/j.euf.2016.02.001, VOL. 3, NO. 1, (119-129), Online publication date: 1-Feb-2017. Martin C, Nolen H, Podolnick J and Wang R (2016) Current and emerging therapies in premature ejaculation: Where we are coming from, where we are goingInternational Journal of Urology, 10.1111/iju.13202, VOL. 24, NO. 1, (40-50), Online publication date: 1-Jan-2017. Men C, Yu L, Yuan H and Cui Y (2016) Efficacy and safety of phosphodiesterase type 5 inhibitors on primary premature ejaculation in men receiving selective serotonin reuptake inhibitors therapy: a systematic review and meta-analysisAndrologia, 10.1111/and.12540, VOL. 48, NO. 9, (1066-1073), Online publication date: 1-Nov-2016. Moudi E and Kasaeeyan A (2016) Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature EjaculationNephro-Urology Monthly, 10.5812/numonthly.32286, VOL. 8, NO. 1 Swerdloff R and Wang C (2016) Sexual Dysfunction Endocrinology: Adult and Pediatric, 10.1016/B978-0-323-18907-1.00123-2, (2154-2162.e3), . McMahon C (2015) Current and Emerging Treatments for Premature EjaculationSexual Medicine Reviews, 10.1002/smrj.49, VOL. 3, NO. 3, (183-202), Online publication date: 1-Jul-2015. Polat E, Ozbek E, Otunctemur A, Ozcan L and Simsek A (2014) Combination therapy with selective serotonin reuptake inhibitors and phosphodiesterase-5 inhibitors in the treatment of premature ejaculationAndrologia, 10.1111/and.12289, VOL. 47, NO. 5, (487-492), Online publication date: 1-Jun-2015. Gur S and Sikka S (2015) The characterization, current medications, and promising therapeutics targets for premature ejaculationAndrology, 10.1111/andr.12032, VOL. 3, NO. 3, (424-442), Online publication date: 1-May-2015. Mirone V and Fusco F (2015) Premature Ejaculation Clinical Uro-Andrology, 10.1007/978-3-662-45018-5_7, (123-132), . Cai T, Pisano F, Magri V, Verze P, Mondaini N, D'Elia C, Malossini G, Mazzoli S, Perletti G, Gontero P, Mirone V and Bartoletti R (2014) Chlamydia trachomatis Infection Is Related to Premature Ejaculation in Chronic Prostatitis Patients: Results from a Cross‐Sectional StudyThe Journal of Sexual Medicine, 10.1111/jsm.12699, VOL. 11, NO. 12, (3085-3092), Online publication date: 1-Dec-2014. Althof S, McMahon C, Waldinger M, Serefoglu E, Shindel A, Ganesan Adaikan P, Becher E, Dean J, Giuliano F, Hellstrom W, Giraldi A, Glina S, Incrocci L, Jannini E, McCabe M, Parish S, Rowland D, Taylor Segraves R, Sharlip I and Torres L (2014) An Update of the International Society of Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE)The Journal of Sexual Medicine, 10.1111/jsm.12504, VOL. 11, NO. 6, (1392-1422), Online publication date: 1-Jun-2014. Althof S, McMahon C, Waldinger M, Serefoglu E, Shindel A, Adaikan P, Becher E, Dean J, Giuliano F, Hellstrom W, Giraldi A, Glina S, Incrocci L, Jannini E, McCabe M, Parish S, Rowland D, Segraves R, Sharlip I and Torres L (2014) An Update of the International Society of Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE)Sexual Medicine, 10.1002/sm2.28, VOL. 2, NO. 2, (60-90), Online publication date: 1-Jun-2014. Gajjala S and Khalidi A (2014) Premature ejaculation: A reviewIndian Journal of Sexually Transmitted Diseases and AIDS, 10.4103/0253-7184.142391, VOL. 35, NO. 2, (92), . Teloken P and Mulhall J (2014) Premature Ejaculation Men's Sexual Health and Fertility, 10.1007/978-1-4939-0425-9_8, (129-144), . Lee W, Lee S, Cho S, Lee Y, Oh C, Yoo C, Cho J, Lee S and Yang D (2013) Comparison Between On‐Demand Dosing of Dapoxetine Alone and Dapoxetine Plus Mirodenafil in Patients with Lifelong Premature Ejaculation: Prospective, Randomized, Double‐Blind, Placebo‐Controlled, Multicenter StudyThe Journal of Sexual Medicine, 10.1111/jsm.12287, VOL. 10, NO. 11, (2832-2841), Online publication date: 1-Nov-2013. Ciocca G, Limoncin E, Mollaioli D, Gravina G, Di Sante S, Carosa E, Lenzi A and Jannini E (2019) Integrating psychotherapy and pharmacotherapy in the treatment of premature ejaculationArab Journal of Urology, 10.1016/j.aju.2013.04.011, VOL. 11, NO. 3, (305-312), Online publication date: 1-Sep-2013. McMahon C, Jannini E, Waldinger M and Rowland D (2013) Standard Operating Procedures in the Disorders of Orgasm and EjaculationThe Journal of Sexual Medicine, 10.1111/j.1743-6109.2012.02824.x, VOL. 10, NO. 1, (204-229), Online publication date: 1-Jan-2013. Shindel A, Chen J and Sharlip I (2013) Complementary, Surgical, and Experimental Modalities for Management of Premature Ejaculation Premature Ejaculation, 10.1007/978-88-470-2646-9_24, (305-329), . Waldinger M (2013) Treatment of Premature Ejaculation with Selective Serotonin Re-Uptake Inhibitors Premature Ejaculation, 10.1007/978-88-470-2646-9_19, (229-240), . Adaikan P and Srilatha B (2013) Choice of Pharmacologic Agents Men's Health, 10.1007/978-1-4471-4766-4_20, (133-136), . McMahon C (2012) Management of premature ejaculationHuman Andrology, 10.1097/01.XHA.0000415235.79085.e6, VOL. 2, NO. 4, (79-93), Online publication date: 1-Dec-2012. Steggall M (2012) Pharmacological management of premature ejaculationNurse Prescribing, 10.12968/npre.2012.10.11.545, VOL. 10, NO. 11, (545-550), Online publication date: 1-Nov-2012. Asimakopoulos A, Miano R, Agrò E, Vespasiani G and Spera E (2012) Current Scientific and Clinical the of Phosphodiesterase Type 5 Inhibitors for the Treatment of Premature A Systematic Review and Journal of Sexual Medicine, VOL. 9, NO. 9, Online publication date: Giuliano F, P and (2012) for the Treatment of Premature Reviews, VOL. NO. 3, Online publication date: and T (2012) and EjaculationThe Journal of Sexual Medicine, VOL. 9, NO. 4, Online publication date: Mulhall J (2012) Premature Ejaculation Urology, . McMahon C and H Oral Agents for the Treatment of Premature Ejaculation: Review of Efficacy and Safety in the of the International Society for Sexual Medicine for Lifelong Premature EjaculationThe Journal of Sexual Medicine, VOL. 8, NO. 10, Online publication date: Jannini E, McMahon C, Chen J, A and M The of Phosphodiesterase Type 5 Inhibitors in the Treatment of Premature EjaculationThe Journal of Sexual Medicine, VOL. 8, NO. 8, Online publication date: J, Liu S, H, V, C, Yu H and C The of An VOL. NO. 2, Online publication date: T and C The Comparison of Combination and to in Men with Premature of Pharmacotherapy, VOL. NO. Online publication date: Z, Zhu Y, Yuan Y, Cui W, Jin Z, Li and Liu T Current for premature ejaculation and Journal of Andrology, VOL. NO. 4, Online publication date: A, D, R, M, Spera G and Lenzi A Is there a role for phosphodiesterase inhibitors in the treatment of premature Journal of Impotence Research, VOL. 23, NO. 1, Online publication date: Human of Medicine, . McMahon C Premature Ejaculation Practical and . A, A, F and O of ejaculation latency time and the effects of on on premature double-blind, Urology and VOL. NO. 4, Online publication date: Steggall M Premature ejaculation: assessment and clinical Journal of Urological VOL. 4, NO. 3, Online publication date: C, P, and Hellstrom in the Diagnosis and Treatment of Premature Urology VOL. 11, NO. 6, Online publication date: Althof S, C, Dean J, G, McCabe M, McMahon C, R, R, Waldinger M, Becher E, G, J, I, A, Giuliano F, Hellstrom W, Incrocci L, Jannini E, K, Parish S, H, Rowland D, Segraves R, Sharlip I, C and H International Society for Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature EjaculationThe Journal of Sexual Medicine, VOL. NO. 9, Online publication date: Lee J for the of SSRIs in Premature Ejaculation Journal of Sexual Medicine, VOL. NO. 8, Online publication date: Steggall M Premature ejaculation: assessment and in Urology, Sexual Health, VOL. NO. 3, Rowland D, McMahon C, C, Chen J, Jannini E, Waldinger M and T Disorders of Orgasm and Ejaculation in Journal of Sexual Medicine, VOL. NO. 4, Online publication date: E and Premature ejaculation: treatment Journal of AIDS, VOL. NO. 2, Online publication date: A, N, A, J, S, G, S, D, C, E and A sexual of and 50 compared with paroxetine in male An study using the of VOL. 24, NO. 1, Online publication date: J, A and R VOL. 8, NO. 1, Online publication date: A, M, D, R, Spera E, G and Spera G Effects of on ejaculatory latency time in men with premature Journal of Impotence Research, VOL. NO. 4, Online publication date: Lee H, J, Yang J, D and Lee S A of seminal in seminal in the Journal of Impotence Research, VOL. NO. 1, Online publication date: Clinical Management in G, L and Hellstrom Diagnosis and Treatment of Ejaculatory Dysfunction and Assisted Reproduction, Giuliano F and Hellstrom The treatment of premature VOL. NO. 6, Online publication date: N and B Premature ejaculation: a clinical Journal of VOL. NO. 11, Online publication date: H and R Premature Ejaculation: Current Treatment and Journal of Sexual Medicine, VOL. 5, NO. 5, Online publication date: Rowland D and McMahon C Premature Ejaculation of Sexual and Disorders, Online publication date: W, W, H and Y of Premature Journal of Urology, VOL. 49, NO. 9, . P Pharmacological treatment of premature VOL. NO. 1, Online publication date: Chen J, G, Y and H The of Phosphodiesterase Type 5 Inhibitors in the Management of Premature Ejaculation: A of and Clinical Urology, VOL. NO. 5, Online publication date: M Safety and Efficacy of in the Treatment of Premature of Clinical VOL. NO. 5, Online publication date: A, L, M and G of Phosphodiesterase Type 5 Inhibitors for Urological and Urology, VOL. NO. 4, Online publication date: Waldinger M, A, B and D The of Men with Lifelong Premature Ejaculation An Study in a Group of Journal of Sexual Medicine, VOL. 4, NO. 4, Online publication date: W, L, S and D Selective serotonin reuptake inhibitors in the treatment of premature VOL. NO. 11, Online publication date: for Premature Ejaculation Sexual M, E and Hellstrom a selective serotonin for the treatment of premature and Clinical VOL. 3, NO. 2, Online publication date: Wang W, Wang Y, S and D sildenafil primary premature A clinical Journal of Urology, VOL. NO. 4, Online publication date: Waldinger M Premature VOL. NO. 4, . K and D Phosphodiesterase Type 5 The Urology, VOL. NO. 1, Online publication date: and Sildenafil in the treatment of erectile an overview of the clinical in VOL. 1, NO. 4, Online publication date: Hellstrom and J Treatment of premature ejaculation: new drugs and treatment Urology VOL. NO. 6, Online publication date: Hellstrom and J Treatment of premature ejaculation: drugs and treatment Sexual Health VOL. 3, NO. 4, Online publication date: M A Combination Treatment for Premature Ejaculation: A Journal of Sexual Medicine, VOL. 3, NO. 6, Online publication date: Hellstrom Current and of Premature EjaculationThe Journal of Sexual Medicine, VOL. 3, Online publication date: Sharlip I Guidelines for the Diagnosis and Management of Premature EjaculationThe Journal of Sexual Medicine, VOL. 3, Online publication date: Segraves R ejaculation: a review of prevalence and Journal of Impotence Research, VOL. NO. Online publication date: Jannini E, Carosa E, M, F and Lenzi A Update on of Premature Ejaculation: The for Pharmacological Update VOL. 4, NO. 4, Online publication date: I, R, C, A and A (2018) Sildenafil in of Urology, VOL. NO. 6, Online publication date: Waldinger M Emerging drugs for premature ejaculationExpert Opinion on Emerging VOL. 11, NO. 1, Online publication date: N, M, M, D, D and S (2013) and of Dapoxetine a for the Treatment of Premature EjaculationThe Journal of Clinical VOL. NO. 3, Online publication date: Althof S (2018) and of Premature of Urology, VOL. NO. 3, Online publication date: clinical in lower sexual Journal of VOL. NO. Online publication date: A, M, A, M, K and Comparison of efficacy of sildenafil plus and in treatment of premature VOL. NO. 2, Online publication date: M, D, S, A and N a treatment for premature not with phosphodiesterase-5 Journal of Impotence Research, VOL. NO. 1, Online publication date: Mulhall J Current and pharmacotherapeutic in treatment of premature VOL. NO. 1, Online publication date: McMahon C Ejaculatory Disorders Sexual R and G Oral for Erectile Dysfunction Sexual . Abdel-Hamid I a for the treatment of VOL. 10, NO. Online publication date: McMahon C The and management of premature Clinical Urology, VOL. 2, NO. 9, Online publication date: G, H and I and a update of Journal of Clinical VOL. NO. 6, McMahon C, M, K, N, S and M Efficacy of Sildenafil in Men with Premature EjaculationThe Journal of Sexual Medicine, VOL. 2, NO. 3, Online publication date: R, S, M, A, L, A, F, Mondaini N, G, S, F, G and M and of phosphodiesterase type 5 in human and of VOL. 11, NO. 2, Online publication date: M and Hellstrom for Ejaculatory Disorders and Erectile Dysfunction in the Andrology, D Sexual dysfunction associated with Opinion on VOL. 3, NO. 5, Online publication date: Waldinger M, A, D and B of for the of efficacy of drug treatment of premature ejaculation: a systematic review and Journal of Impotence Research, VOL. NO. 4, Online publication date: McMahon C, C, Incrocci L, M, Rowland D, Waldinger M and Z Disorders of Orgasm and Ejaculation in Journal of Sexual Medicine, VOL. 1, NO. 1, Online publication date: D, J, G, R, J, T, A and I (2018) of Urology, VOL. NO. 1, Online publication date: Waldinger M Lifelong premature ejaculation: from to VOL. NO. 2, Online publication date: McMahon C Ejaculatory Dysfunction and Sexual . Waldinger M Premature Ejaculation: and Treatment to and Sexual . P Serotonin in the and and of . J, and M (2016) Erectile International Journal of in Medicine, VOL. NO. 3, Online publication date: Mondaini N, R, G, F, Di F, G and M Sildenafil not sexual function in men without erectile dysfunction but the Journal of Impotence Research, VOL. NO. 3, Online publication date: 2002 by American Urological Association, ANDREA SALONIA by this TOMMASO MAGA by this RENZO COLOMBO by this VINCENZO SCATTONI by this ALBERTO BRIGANTI by this ANDREA CESTARI by this GIORGIO GUAZZONI by this PATRIZIO RIGATTI by this FRANCESCO MONTORSI by this All
BACKGROUND: Identifying what therapies constitute complementary, alternative, and/or integrative medicine (CAIM) is complex for a multitude of reasons. An operational definition is dynamic, and changes based on both historical time period and geographical location whereby many jurisdictions may integrate or consider their traditional system(s) of medicine as conventional care. To date, only one operational definition of "complementary and alternative medicine" has been proposed, by Cochrane researchers in 2011. This definition is not only over a decade old but also did not use systematic methods to compile the therapies. Furthermore, it did not capture the concept "integrative medicine", which is an increasingly popular aspect of the use of complementary therapies in practice. An updated operational definition reflective of CAIM is warranted given the rapidly increasing body of CAIM research literature published each year. METHODS: Four peer-reviewed or otherwise quality-assessed information resource types were used to inform the development of the operational definition: peer-reviewed articles resulting from searches across seven academic databases (MEDLINE, EMBASE, AMED, PsycINFO, CINAHL, Scopus and Web of Science); the "aims and scope" webpages of peer-reviewed CAIM journals; CAIM entries found in online encyclopedias, and highly-ranked websites identified through searches of CAIM-related terms on HONcode. Screening of eligible resources, and data extraction of CAIM therapies across them, were each conducted independently and in duplicate. CAIM therapies across eligible sources were deduplicated. RESULTS: A total of 101 eligible resources were identified: peer-reviewed articles (n = 19), journal "aims and scope" webpages (n = 22), encyclopedia entries (n = 11), and HONcode-searched websites (n = 49). Six hundred four unique CAIM terms were included in this operational definition. CONCLUSIONS: This updated operational definition is the first to be informed by systematic methods, and could support the harmonization of CAIM-related research through the provision of a standard of classification, as well as support improved collaboration between different research groups.
BACKGROUND: Medical pluralism has flourished throughout the Western world in spite of efforts to legitimize Western biomedical healthcare as "conventional medicine" and thereby relegate all non-physician-related forms of healthcare to an "other" category. These "other" practitioners have been referred to as "unconventional", "alternative" and "complementary", among other terms throughout the past half century. METHODS: This study investigates the discourses surrounding the changes in the terms, and their meanings, used to describe unconventional medicine in North America. Terms identified by the literature as synonymous to unconventional medicine were searched using the Scopus database. A textual analysis following the method described by Kripendorff 2013 was subsequently performed on the five most highly-cited unconventional medicine-related peer-reviewed literature published between 1970 and 2013. RESULTS: Five commonly-used, unconventional medicine-related terms were identified. Authors using "complementary and alternative", "complementary", "alternative", or "unconventional" tended to define them by what they are not (e.g., therapies not taught/used in conventional medicine, therapy demands not met by conventional medicine, and therapies that lack research on safety, efficacy and effectiveness). Authors defined "integrated/integrative" medicine by what it is (e.g., a new model of healthcare, the combining of both conventional and unconventional therapies, accounting for the whole person, and preventative maintenance of health). Authors who defined terms by "what is not" stressed that the purpose of conducting research in this area was solely to create knowledge. Comparatively, authors who defined terms by "what is" sought to advocate for the evidence-based combination of unconventional and conventional medicines. Both author groups used scientific rhetoric to define unconventional medical practices. CONCLUSIONS: This emergence of two groups of authors who used two different sets of terms to refer to the concept of "unconventional medicine" may explain why some journals, practitioner associations and research/practice centres may choose to use both "what is not" and "what is" terms in their discourse to attract interest from both groups. Since each of the two groups of terms (and authors who use them) has different meanings and goals, the evolution of this discourse will continue to be an interesting phenomenon to explore in the future.
Journal of Complementary and Alternative Medical Research (ISSN: 2456-6276) aims to publish high quality papers (Click here for Types of paper) in the areas of Complementary, Alternative and Integrative medical research. This journal facilitates the research and wishes to publish papers as long as they are technically correct, scientifically motivated. The journal also encourages the submission of useful reports of negative results. This is a quality controlled, OPEN peer reviewed, open access INTERNATIONAL journal. The coverage includes Botanical Medicine, Acupuncture and Traditional Chinese Medicine, Chiropractic Medicine, Mind-Body Medicine, Herbal medicine, Nutrition and Dietary Supplements, Yoga, Ayurveda, Naturopathy, Homeopathy, Tai Chi, Qi Gung, Massage Therapy, Subtle Energies and Energy Medicine, Magnetic Field Therapy, Reiki, Neurostimulation, Integrative Biophysics and other allied areas. Every volume of this journal will consist of 4 issues. Every issue will consist of minimum 5 papers. Each issue will be running issue and all officially accepted manuscripts will be immediately published online. State-of-the-art running issue concept gives authors the benefit of 'Zero Waiting Time' for the officially accepted manuscripts to be published. This journal is an international journal and scope is not confined by boundary of any country or region. This journal has no connection with any society or association, related to Complementary, Alternative and Integrative Medicine or Medical research and allied fields. This is an independent journal run by SDI.
Practitioners and researchers from China, the largest user of complementary and alternative medicine (CAM), have been publishing an increasing number of scientific articles in world-famous CAM journals in recent years. However, the status of CAM research in the three major regions of China, the Mainland, Taiwan and Hong Kong has, until now, not been reported. In this study, we compared articles from these three regions published in international CAM journals from 2000 to 2009 using PubMed database and the Journal Citation Reports. The study results showed that the number of published articles from Mainland China increased significantly from 2000 to 2009, particularly since 2005. Meanwhile, the number of published articles from Taiwan also increased, whereas those from Hong Kong remained steady. Clinical trials and randomized controlled trials from Chinese authors both took a small percentage of the total. The impact factors of the journals in which these articles were published suggested similar academic levels whereas the average number of citation of articles from the Mainland was less than those from the other two regions. Journal of Ethnopharmacology, American Journal of Chinese Medicine, Journal of Alternative and Complementary Medicine and Evidence-based Complementary and Alternative Medicine were the most popular journals for Chinese authors.
BACKGROUND: Coronavirus disease 2019 (COVID-19) is a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2, and responsible for a global pandemic. Despite there being no known vaccines or medicines that prevent or cure COVID-19, many traditional, integrative, complementary and alternative medicines (TICAMs) have been touted as the solution, as well as researched as a potential remedy globally. This study presents a bibliometric analysis of global research trends at the intersection of TICAM and COVID-19. METHODS: SCOPUS, MEDLINE, EMBASE, AMED and PSYCINFO databases were searched on July 5, 2020, with results being exported on the same day. All publication types were included, however, articles were only deemed eligible if they made mention of one or more TICAMs for the potential prevention, treatment, and/or management of COVID-19 or a health issue indirectly resulting from the COVID-19 pandemic. The following eligible article characteristics were extracted: title; author names, affiliations, and countries; DOI; publication language; publication type; publication year; journal (and whether it is TICAM-focused); 2019 impact factor, and TICAMs mentioned. RESULTS: A total of 296 eligible articles were published by 1373 unique authors at 977 affiliations across 56 countries. The most common countries associated with author affiliation included China, the United States, India and Italy. The vast majority of articles were published in English, followed by Chinese. Eligible articles were published across 157 journals, of which 33 were TICAM-focused; a total of 120 journals had a 2019 impact factor, which ranged from 0.17 to 60.392. A total of 327 TICAMs were mentioned across eligible articles, with the most common ones including: traditional Chinese medicine (n = 94), vitamin D (n = 67), melatonin (n = 16), phytochemicals (n = 12), and general herbal medicine (n = 11). CONCLUSIONS: This study provides researchers and clinicians with a greater knowledge of the characteristics of articles that been published globally at the intersection of COVID-19 and TICAM to date. At a time where safe and effective vaccines and medicines for the prevention and treatment of COVID-19 have yet to be discovered, this study provides a current snapshot of the quantity and characteristics of articles written at the intersection of TICAM therapies and COVID-19.
Integrative Medicine combines the concepts, values and practices of complementary and alternative medicine with conventional medicine in the comprehensive diagnosis and treatment of disease. Integrative Medicine is concerned with preventing disease, health maintenance and healing, rather than merely eliminating symptoms. The persons innate healing abilities are actively supported, and the importance of mind and spiritual nature are recognised. Integrative Medicine values the relationship between the healer and the patient to promote self-help and provides the appropriate education and motivation required for patient empowerment. The complementary arm of Integrative Medicine adopts specific therapeutic techniques such as massage, herbal medicine and aromatherapy, or medical paradigms such as Tibb, Ayurveda, Naturopathy, or Homeopathy. Tibb, also known as Unani-Tibb (Graeco-Arabic) medicine, is the historical forerunner of conventional medicine, so it is an attractive partner. Integrative Medicine has a major role in both treatment of acute ailments, mainly through the conventional arm of treatment, and long-term management of chronic disorders, mainly via the complementary arm. Integrative Medicine addresses the increasingly common disorders of lifestyle such as hypertension, heart disease, diabetes 2, and depression.Bangladesh Journal of Medical Science Vol.16(1) 2017 p.13-20
Open science practices aim to increase transparency in research and increase research availability through open data, open access platforms, and public access. Due to the increasing popularity of complementary, alternative, and integrative medicine (CAIM) research, our study aims to explore current open science practices and perceived barriers among CAIM researchers in their own respective research articles. We conducted an international cross-sectional online survey that was sent to authors that published articles in MEDLINE-indexed journals categorized under the broad subject of "Complementary Therapies" or articles indexed under the MeSH term "Complementary Therapies." Articles were extracted to obtain the names and emails of all corresponding authors. Eight thousand seven hundred eighty-six researchers were emailed our survey, which included questions regarding participants' familiarity with open science practices, their open science practices, and perceived barriers to open science in CAIM with respect to participants' most recently published article. Basic descriptive statistics was generated based on the quantitative data. The survey was completed by 292 participants (3.32% response rate). Results indicate that the majority of participants were "very familiar" (n = 83, 31.68%) or "moderately familiar" (n = 83, 31.68%) with the concept of open science practices while creating their study. Open access publishing was the most familiar to participants, with 51.96% (n = 136) of survey respondents publishing with open access. Despite participants being familiar with other open science practices, the actual implementation of these practices was low. Common barriers participants experienced in implementing open science practices include not knowing where to share the study materials, where to share the data, or not knowing how to make a preprint. Although participants responded that they were familiar with the concept of open science practices, the actual implementation and uses of these practices were low. Barriers included a lack of overall knowledge about open science, and an overall lack of funding or institutional support. Future efforts should aim to explore how to implement methods to improve open science training for CAIM researchers.
Integrative medicine has become a vital component of patient care. It provides patient-centered care that is focused on prevention and overall well-being. As there has been a growing number of patients favoring a blend of conventional, complementary and alternative approaches, integrative medicine has exceeded beyond the evaluation of complementary therapies. However, it is noteworthy that there has been a dilemma of providing substantial evidence supporting the efficacy of some complementary and alternative therapies. This study's goals were to analyze publication trends, most productive journals, most productive funding agencies, most productive authors, most relevant keywords, and countries in the field of integrative medicine research. Additionally, science mapping included country collaboration analysis and thematic evolution analysis. The findings from this study showed a constant rise in annual growth of publications from 2000 to 2019; the United States was dominant in various analysis categories. In conclusion, a comprehensive review of the evolution of research of integrative medicine will help healthcare providers understand an overview of the present status while encouraging more evidence-based research for the betterment of integrative patient care.